James Welsh, MS, MD, FACRO, is a board-certified radiation oncologist and neuro-oncologist who served on the Advisory Committee on the Medical Uses of Isotopes, which advises the NRC on medical issues, from 2007-2014.

Dr. Welsh obtained his master’s degree in molecular biophysics and biochemistry from Yale University and his M.D. from the State University of New York at Stony Brook. He completed his residency training at The Johns Hopkins Hospital in Baltimore, Maryland and stayed on the Johns Hopkins faculty as an Assistant Professor of Oncology until 2001. Subsequently, Dr. Welsh completed a fellowship at the University of Wisconsin investigating helical TomoTherapy, a newly developed form of image-guided, intensity-modulated radiotherapy technology. He joined the faculty at the University of Wisconsin and became Clinical Professor of Human Oncology and Medical Physics. From there, Dr. Welsh served brief stints as Professor of Neurosurgery and Radiology at the Louisiana State University School of Medicine–Shreveport and as a radiation oncologist at Willis-Knighton Hospital. He then returned to the Midwest as the fast neutron therapy physician at the Northern Illinois University Institute for Neutron Therapy at Fermilab.

Dr. Welsh is currently Professor, Medical Director, and Director of Clinical & Translational Research in the Department of Radiation Oncology at the Stritch School of Medicine at Loyola University-Chicago and Chief of Radiation Oncology at the Hines VA Medical Center. He is also president-elect of the American College of Radiation Oncology and sits on the editorial boards for several scientific and medical journals.

Education

• 1990-94 State University of New York at Stony Brook School of Medicine
  M.D. 1994
• 1985-86 Yale University, New Haven, CT
  M.S. Molecular Biophysics and Biochemistry 1986
• 1980-84 State University of New York at Binghamton
  B.S. Biological Sciences 1984
• 1978-79 Hofstra University, Hempstead, NY

Post Graduate Medical Education

• 09/2001 – 09/2002
  Fellowship in Helical Tomotherapy
  University of Wisconsin-Madison
  Department of Human Oncology
  1300 University Ave Madison, WI 53706
  Mentors: Jack Fowler, T. Rockwell Mackie, Minesh P. Mehta
• 07/1995 – 06/1998
  Resident Physician
  The Johns Hopkins Hospital
  Division of Radiation Oncology
  600 N Wolfe Street
Baltimore, MD 21287
• 06/1994 – 07/1995
  Medical Internship
  Winthrop University Hospital
  Department of Internal Medicine
  259 First Street
  Mineola, NY 11501-3987

University Appointments

• 2014-present
  Professor, Medical Director, Director of Clinical & Translational Research
  Department of Radiation Oncology
  Loyola University Stritch School of Medicine
  Maywood, IL
• 2012-2015
  Adjunct Professor of Physics
  Northern Illinois University
• 2012-2014
  Adjunct Professor of Chemistry & Biochemistry
  Northern Illinois University
• 2012-2014
  Adjunct Professor of Biological Sciences
  Northern Illinois University
  DeKalb, IL
• 2010-2011
  Full Professor. Department of Radiology
  Louisiana State University School of Medicine
  Shreveport, LA
• 2010-2011
  Full Professor. Department of Neurosurgery
  Louisiana State University School of Medicine
  Shreveport, LA
• 2010-present
  Honorary Fellow, Department of Medical Physics
  University of Wisconsin School of Medicine and Public Health
  Madison, Wisconsin
• 2009-2010
  Clinical Professor of Human Oncology
  University of Wisconsin School of Medicine and Public Health
  Madison, Wisconsin
• 2009-2010
  Clinical Professor of Medical Physics
  University of Wisconsin School of Medicine and Public Health
• 2007-09
  Clinical Associate Professor of Medical Physics
  University of Wisconsin School of Medicine and Public Health
• 2005-09
  Clinical Associate Professor of Human Oncology
  University of Wisconsin School of Medicine and Public Health
• 2003-05
  Clinical Assistant Professor of Human Oncology
  University of Wisconsin School of Medicine and Public Health
• 2001-2002
  Clinical Instructor/Fellow of Human Oncology
  University of Wisconsin School of Medicine and Public Health
• 2000-2001
  Assistant Professor of Oncology
  The Johns Hopkins University School of Medicine
• 1998-2000
  Instructor of Oncology
  Johns Hopkins University School of Medicine Baltimore, MD

Administrative Positions

• 2017 – present
  Chairman/Chief of Radiation Oncology Service Edward Hines Jr VA Hospital
Maywood, IL
• 2015 – 2017
  Medical Director of Radiation Oncology (contracted) Edward Hines Jr VA Hospital
Maywood,, IL
• 2014 – 2016
  Medical Director
Department of Radiation Oncology
Loyola University Stritch School of Medicine Maywood, IL
• 2008-2010
  Chief of Radiation Oncology
University of Wisconsin Cancer Center-Riverview Department of Radiation Oncology, Riverview Hospital Wisconsin Rapids, WI
• 2007-2008
  Chief of Oncology (Medical and Radiation Oncology) University of Wisconsin Cancer Center-Riverview Riverview Hospital
Wisconsin Rapids, WI
• 2004-2007
  Medical Director (Medical and Radiation Oncology) University of Wisconsin Cancer Center-Riverview Riverview Hospital
  Wisconsin Rapids, WI

Security Clearance

• 2008-2015 US DOE L Clearance (equivalent of DoD SECRET)

Federal Advisory Committee Appointments

• 2018-present
  ROFAC (Radiation Oncology Federal Advisory Committee)
• 2006-present
  Advisory Committee on the Medical Use of Isotopes (ACMUI) United States Nuclear Regulatory Commission (NRC)

Specific ACMUI Advisory Committee Work:

• Subcommittee Chair: Permanent implant brachytherapy subcommittee.
• Subcommittee Chair : Medical events subcommittee.
Subcommittee member: Y-90 Microsphere Brachytherapy Subcommittee.
• Subcommittee member: Radioiodine patient release subcommittee.
• Subcommittee member: 223RaCl2 subcommittee.
• Subcommittee member: 10 CFR Part 35 Rulemaking subcommittee.

Consultant

In addition to membership in the United States Nuclear Regulatory Commission (NRC) Advisory Committee on the Medical Use of Isotopes (ACMUI) I have provided independent consultation to the NRC on specific cases since 2008 to help the agency ascertain if these situations met the formal definition of “Medical Event” (formerly “Misadministration”)

Hospital & Clinic Appointments:

• 2015 – present Northwestern Medicine Chicago Proton Therapy Center (Proton beam therapy privileges)
• 2015 – present Edward Hines Jr VA Hospital. Hines, IL
• 2014 – present Loyola University Hospital and Clinics. Maywood, IL
• 2014 OSF St Francis Hospital, Peoria, IL (locums tenens)
• 2013 Morris Hospital, Morris, IL
• 2012 Elmhurst Hospital, Elmhurst, IL
• 2012 NIU Institute for Neutron Therapy at Fermilab Fermi National Accelerator Laboratory, Batavia, IL
• 2012 MacNeal Hospital, Berwyn, IL
• 2011 Willis-Knighton Hospital, Shreveport, LA
• 2010-2011 Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA
• 2010 St Michael’s Hospital, Stevens Point WI (locums tenens)
• 2010 St Joseph’s Hosp/Marshfield Clinic, Marshfield, WI (locums tenens)
• 2010 Marshfield Clinic, Minocqua Center, Minocqua, WI (locums tenens)
• 2010 Ministry/St. Mary’s Hosp, Rhinelander, WI (locums tenens)
• 2010 Mercy Medical Center, Oshkosh, WI (locums tenens)
• 2003-2010 Attending Physician, Riverview Hospital, Wisconsin Rapids, WI
• 2001-2010 Attending Physician, UW Hospital and Clinics, Madison, WI
• 2001-2010 Staff Physician, Aspirus Wausau Hospital, Wausau, WI
• 2008-2010 Staff Physician, Langlade Memorial Hospital, Antigo, WI
• 2001-2006 Staff Physician, Holy Family Hospital, Manitowoc, WI
• 2001-2006 Staff Physician, Merriter Hospital, Madison, WI
• 2001-2006 Staff Physician, Freeport Memorial Hospital, Freeport, IL
• 2001-2006 Staff Physician, Beloit Memorial Hospital, Beloit, WI
• 1998-2001 Attending Physician, The Johns Hopkins Hospital, Baltimore, MD

Non-faculty University Appointments

• 1987-1989
  Research Associate
  Department of Psychiatry
  Yale University School of Medicine
• 1985-87
  Research Associate
  Liver Study Center; Division of Gastroenterology;
  Department of Internal Medicine.
  Yale – New Haven Hospital/Yale University School of Medicine
• 1984
  Research Assistant
  Department of Chemistry,
  State University of New York at Binghamton

Board Certifications


1. Radiation Oncology
   Diplomate of the American Board of Radiology Board Certification in Radiation Oncology, 1999
   Re-certification 2009

2. Neuro-Oncology
   Diplomate of the United Council for Neurological Subspecialties
   Board Certification in Neuro-Oncology, 2009

Medical Licensure

• State of Illinois Department of Professional Regulation (2002-09; 2012-present)
• Louisiana State Board of Medical Examiners (2011 – 2012)
• State of Wisconsin Department of Regulation and Licensing (2001 – 2011)
• State of Maryland Board of Physician Quality Assurance (1998-2001)

Membership in Professional Societies

• Radiological Society of North America (RSNA)
• American Association of Physicists in Medicine (AAPM)
• American Society for Therapeutic Radiology and Oncology (ASTRO)
• American College of Radiation Oncology (ACRO)
• Society for Brain Mapping and Therapeutics (SBMT)
• American College of Radiology (ACR)
• Radiation Research Society
• Health Physics Society
• Radiosurgery Society
• *American Society of Clinical Oncology (ASCO)
  *American Radium Society (ARS)
  *Conference of Radiation Control Program Directors (CRCPD) Affiliate member
  *American Nuclear Society (ANS)
  * No longer active in 2018

Academic Honors and Awards

• Monsignor Farrell High School Hall of Fame 2011
• Fellow of the American College of Radiation Oncology (FACRO) 2006
• Consumers Research Council America’s Top Physicians 2005
• Director’s Teaching Award in Clinical Science
  Johns Hopkins Oncology Center, 1999
• Marquis Who’s Who in The World 2006
• Marquis Who’s Who in America 2005
• Academic Keys Who’s Who in Medicine 2005
• Empire Who’s Who 2005
• Chairman’s Letter of Commendation: Resident with excellent teaching skills
  Winthrop University Hospital, 1994 – 95
• Alpha Omega Alpha – inducted in junior year of medical school
  SUNY Stony Brook
• School of Medicine National Dean’s List
  SUNY Stony Brook School of Medicine
• Phi Beta Kappa
  SUNY Binghamton
• Graduated with “Outstanding Academic Performance”
  SUNY Binghamton
• SUNY Foundation Academic Scholarship for outstanding academic performance, 1984
  SUNY Binghamton
• Provost’s List
  Hofstra University

Service to Professional Organizations, Universities and Community

Service to Professional Organizations

National/International Professional Organization Positions:

1. American College of Radiation Oncology (ACRO):
   • Chairman of the Board 2017-present
   • President  2015-2017
   • Vice President 2013-2015
   • Board of Chancellors 2007-present
   • Standards on Radiation Oncology Practice Committee Chair 2009-2010
   • Scientific Program Committee
     Chair 2007-09
     Co-Chair 
2005-06
     Member 2004, 2010, 2011, 2012
   • ACRO Accreditation Program
Disease Site Leader (Lymphoma and Sarcoma) 2010-2011
     Member, 2011 – present
2. Radiological Society of North America (RSNA):
   • Radiation Oncology/Radiobiology Scientific Program Subcommittee
     Chair 2006-2009
     Subcommittee Member 2004-06
   • Radiation Oncology/Radiobiology Educational Exhibits Panel
     Member 2010 – present
   • Oncologic Imaging and Therapies Task Force
     Member 2007-2010
   • Bolstering Oncoradiodiagnostic and Oncoradotherapeutic Skills for Tomorrow (BOOST)
     Committee 
Member 2007-2010
   • Scientific Program and Annual Assembly Selection Committee for Medical Student Award and Resident/Fellow Research Trainee Prize (2004, 2005, 2006, 2007, 2008 and 2009)
   • Selection Committee for Educational Exhibit Awards 2006
3. American Society of Therapeutic Radiology and Oncology (ASTRO):
   • NRC Subcommittee
     Immediate past Chair 2013 – present
     Chair  2010 – 2013
     Vice Chair  2009 – 2010
     Member  2006 – 2009
   • ASTRO Government Relations Committee, Government Relations Council
     Sub-Chair 2010-2012
     Member 2005-2010; 2013 – present
   • History Committee
     Member 2009-2015
   • Education Committee
     • Co-Chair: Subcommittee on Systemic Targeted Radiation Therapy (“STaRT 2”)
     • Education Council: Member 2007-2013
   • Governmental Affairs Committee
     Liaison between Nuclear/Radiologic Response Committee and NRC Subcommittee. 2007-2009
4. American College of Radiology (ACR):
   • ACR Federal Regulatory Committee (2016 – present)
   • CARROS (Council of Affiliated Regional Radiation Oncology Societies – a chapter of the ACR): Membership Committee (2015 – present)
   • Co-Chair: AIRP Radiation Oncology (AIRP-RO) course (2016)
   • Commission on Radiation Oncology. Member. 2011-present
   • Alternate Councilor (Representing the American College of Radiation Oncology) 2010-present
   • Committee on Education. Member 2007-2009
   • Medical Physics Caucus 2017-present
   • Membership Committee: 2016-present

5. Society for Brain Mapping and Therapeutics (SBMT)
   • Board of Directors 
2013 – present
   • Liaison to American College of Radiation Oncology 
2013 – present

State Professional Organization Positions

• Wisconsin Genetics Advisory Council (2006-2010)
• Wisconsin Division of Public Health
  • Medical Sub-Specialty Representative to the Council: Clinical Oncology
  • Travelling Genetics Grand Rounds Program, Lecturer 2006-2010

National Meeting Scientific Program Organizer

• ACRO Proton Beam Therapy Symposium 2017 & 2018 Co-chair and organizer
• Kukuna-o-kala (ACRO Winter Meeting) 2016 Program committee (also for 2017-18)
Course co-director. American Institute for Radiologic Pathology (AIRP) Radiation Oncology course. (Note– this program was scheduled for March 2016 but was cancelled due to insufficient funding)
• American College of Radiation Oncology (ACRO) 2014 and 2015: General program chair
• Program session co-organizer (isotope production via nuclear reactors subsection): 8th International Symposium on Isotopes. Chicago, IL Aug 2014
• Principal Program co-organizer: “Joint Symposium 2013 on Carbon Ion Radiotherapy – Fostering International Collaboration between Japan and the United States in Carbon Ion Radiotherapy”
A two day symposium sponsored by: Mayo Clinic Department of Radiation Oncology, Japan National Institute of Radiological Sciences, and Northern Illinois University Institute for Neutron Therapy at Fermilab
  Double Tree Hotel, Rochester, MN – May 2-3, 2013
• Society for Brain Mapping and Therapeutics (SBMT) 2013-14: Creator of ACRO symposium on neuro- radiation oncology and stereotactic radiosurgery. (March 2014, Sydney, Australia.)
• Radiological Society of North America (RSNA) 2007-09: Radiation Oncology Scientific Program Session Builder and meeting subsection chairman
• American College of Radiation Oncology (ACRO) 2008-09: Scientific program designer/co-chair

National/International Meeting Abstract Reviewer

• American College of Radiation Oncology (ACRO) 2016: Abstract reviewer (Physics, Radiobiology)
• American College of Radiation Oncology (ACRO) 2015: Abstract reviewer (Physics, CNS)
• 8th International Symposium on Isotopes. Chicago, IL Aug 2014
American College of Radiation Oncology (ACRO) 2014: Abstract reviewer (all sections)
• American College of Radiation Oncology (ACRO) 2013: Abstract reviewer (all sections)
• American College of Radiation Oncology (ACRO) 2012: Abstract reviewer (Physics, CNS)
• American College of Radiation Oncology (ACRO) 2011: Abstract reviewer (all sections)
• Radiological Society of North America (RSNA) 2011: Reviewer (educational exhibits)
• American College of Radiation Oncology (ACRO) 2010: Abstract reviewer (all sections)
• Radiological Society of North America (RSNA) 2010: Reviewer (educational exhibits)
• Radiological Society of North America (RSNA) 2010: Reviewer (scientific papers: CNS)
• American College of Radiation Oncology (ACRO) 2009: Abstract reviewer (all sections)
• Radiological Society of North America (RSNA) 2009: Reviewer (all sections)
• American College of Radiation Oncology (ACRO) 2008: Abstract reviewer (all sections)
• Radiological Society of North America (RSNA) 2008: Reviewer for Radiobiology
• American College of Radiation Oncology (ACRO) 2007: Abstract reviewer (all sections)
• Radiological Society of North America (RSNA) 2007: Reviewer for Radiobiology
• American College of Radiation Oncology (ACRO) 2006: Abstract reviewer (all sections)
• Radiological Society of North America (RSNA) 2006: Reviewer for Radiobiology & Radiation Oncology (Genitourinary, Breast, and Benign disease)
• Second Annual Symposium on Liver Directed Microsphere Radiotherapy 2006
• RSNA 2005: Reviewer for Radiobiology, GU, Breast, Benign disease
• RSNA 2004: Reviewer for GU and Breast RSNA 2004: Reviewer for Radiobiology
• American Society of Therapeutic Radiology and Oncology (ASTRO) 2003: Reviewer forGenitourinary (GU) section
• American Society of Therapeutic Radiology and Oncology (ASTRO) 2002: Reviewer for Genitourinary (GU) section

Presiding Officer/Session Chair at National Meetings

• Moderator: Scientific presentations – 2016 Annual Meeting of the American College of Radiation Oncology. March 2016, Orlando, FL
• Session Co-Chair: Outcomes and Quality of Life. Integrated Science-to-Practice Scientific paper oral presentation session. 101th Scientific Assembly and Annual Meeting of the Radiological Society of North America, Nov 2015, Chicago IL.
• Moderator: Scientific presentations – 2015 Annual Meeting of the American College of Radiation Oncology. May 2015, Washington, DC
• Session Co-chair: ACRO CME Symposium: Neuro-radiation oncology and stereotactic radio-surgery. 11th Annual World Congress of the SBMT 2014 – Bringing Together Engineering, Art, Science and Medicine. March 2014.
• Session Chair: Stereotactic Radiosurgery and IMRT. 10th Annual World Congress of the SBMT May 12, 13, 14, 2013
• Moderator: Plenary Session V – Intermediate and high grade lymphomas. 2013 Annual Meeting of the American College of Radiation Oncology. Feb 2013, San Antonio, TX
• Session Chair: Central Nervous System. Integrated Science-to-Practice Session. 97th Scientific Assembly and Annual Meeting of the RSNA, Nov 2011, Chicago IL.
Session Chair: Quality of Life.. 97th Scientific Assembly and Annual Meeting of the RSNA, Nov 2011, Chicago IL.
• Moderator: Plenary Session on New Technologies in radiation therapy. 21stAnnual Meeting of the American College of Radiation Oncology. Feb 2011, San Diego, CA
• Session Chair: Central Nervous System. Integrated Science-to-Practice Session. 96th Scientific Assembly and Annual Meeting of the RSNA, Nov 2010, Chicago IL.
• Moderator: Plenary Session on Radiobiology in the Clinic. 20th Annual Meeting of the American College of Radiation Oncology. Feb 2010, Orlando, FL
• Session Co-chair: “How Much Diagnostic Radiology Training does a Radiation Oncology Resident Need?” 2009 RSNA Scientific Program and Annual Assembly. Chicago, IL. Nov 2009.
• Session Chair: Radiobiology. Scientific paper oral presentation session. 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America, Nov 2009, Chicago IL.
• Moderator: Plenary Session on Radiobiology and CNS Malignancies. 19thAnnual Meeting of the American College of Radiation Oncology. Feb 2009, Las Vegas, NV
• Session Chair: Breast Cancer. Scientific paper oral presentation session. 94th Scientific Assembly and Annual Meeting of the Radiological Society of North America, Nov 2008, Chicago Ill.
• Moderator: Plenary Session on GI Malignancies. 18th Annual Meeting of the American College of Radiation Oncology. Feb 2008, Miami, FL
• Session Chair: Radiation Biology. Scientific paper oral presentation session. 93rd Scientific Assembly and Annual Meeting of the Radiological Society of North America, Nov 2007, Chicago Ill.
• Moderator: Plenary session – New technologies. 17th Annual Meeting of the American College of Radiation Oncology. Feb 2007, San Diego, CA.
• Moderator: Prostate cancer: Biological advances and the latest in practical clinical management. 17th Annual Meeting of the American College of Radiation Oncology. Feb 2007, San Diego, CA.
• Session Chair: Radiation Biology and Lymphoma. Scientific paper oral presentation session. 92nd Scientific Assembly and Annual Meeting of the RSNA, Nov 2006, Chicago Ill.
• Moderator: Plenary Session on Targeted Radiotherapy. 16th Annual Meeting of the American College of Radiation Oncology. Feb 2006, Orlando, FL.
• Session Moderator. Second Annual Symposium on Liver Directed Microsphere Radiotherapy Scottsdale AZ. April, 2006
• Session Chair: Genitourinary cancer. Scientific paper oral presentation session. 91st Scientific Assembly and Annual Meeting of the RSNA, 2005, Chicago Ill.
• Moderator: Genitourinary Cancer Management. 15th Annual Meeting of the American College of Radiation Oncology. Feb 2005, Las Vegas, NV.
• Session Chair: Plenary Session – Invited papers from ASTRO. Scientific Assembly and Annual Meeting of the RSNA, 2004, Chicago Ill.
• Session Chair: Genitourinary cancer. Scientific paper oral presentation session. 90th Scientific Assembly and Annual Meeting of the RSNA, 2004, Chicago Ill.
• Moderator: Intensity Modulated Radiation Therapy. 14th Annual Meeting of The American College of Radiation Oncology. Feb 2004, Orlando FL.
• Session Chair: Gastrointestinal cancer. Scientific paper oral presentation session. 89th Scientific Assembly and Annual Meeting of the RSNA, 2003, Chicago Ill.
• Session Chair: Non-malignant disease, quality of life and outcomes research. 89th Scientific Assembly and Annual Meeting of the RSNA, 2003, Chicago Ill.
• Session Chair: Breast cancer. 89th Scientific Assembly and Annual Meeting of the RSNA, 2003, Chicago Ill.
• Session Chair: Radiobiology. Scientific paper oral presentation session. 88th Scientific Assembly and Annual Meeting of the RSNA, 2002, Chicago Ill.
• Session Chair: Genitourinary radiotherapy. Scientific Poster session. 88th Scientific Assembly and Annual Meeting of the RSNA, 2002, Chicago Ill.
• Session Chair: Genitourinary radiotherapy. Scientific paper oral presentation session. 88th Scientific Assembly and Annual Meeting of the RSNA, 2002, Chicago Ill.

Policy and Guidelines Committees

• American College of Radiology (ACR)/American Society of Therapeutic Radiology and Oncology (ASTRO): Principal drafting committee for practice guidelines for stereotactic body radiation therapy. 2008 (revision of 2004 document)
• American College of Radiology (ACR)/American Society of Therapeutic Radiology and Oncology (ASTRO)/Society of Interventional Radiology (SIR)
  Principal drafting committee for Collaborative Practice Guidelines for Radiolabeled Microsphere Infusionfor Treatment of Liver Malignancies. 2007
• Electronic Brachytherapy Stakeholders’ Group
  Proposed State Regulations for physician use of electronic brachytherapy devices. 2007.
  (Consisting of representatives from the ASTRO, ACR ACRO, the American Association of Physicists in Medicine and the American Brachytherapy Society)
• American College of Radiology (ACR) Radiation Oncology Carrier Advisory Committee (CAC) Network Model Policy on Microsphere Brachytherapy. 2006.
• American College of Radiology (ACR)/American Society of Therapeutic Radiology and Oncology (ASTRO): Principal drafting committee for practice guidelines for stereotactic body radiation therapy. 2004.

Local Hospital Service

• Clinical Chief of Radiation Oncology. Hines VA Medical Center. Maywood, IL 2015-17 (Contracted)
• Radiation Safety Committee, Hines VA Hospital, 2016- present
• Radiation Safety Committee, Elmhurst Hospital, Elmhurst, IL 2012-13
• Radiation Safety Committee, Willis-Knighton Hospital, Shreveport, LA. 2011
• Chief of Radiation Oncology Riverview Hospital/UW Cancer Center-Riverview Hospital, Wisconsin Rapids, WI. 2008-2009
• Chief of Oncology Riverview Hospital/UW Cancer Center-Riverview. 2007-08
• Medical Director Riverview Hospital/UW Cancer Center-Riverview. 2004-2007
• Founder/Chair of Radiological Disaster Subcommittee, Riverview Hospital 2007
• Radiation Safety Committee, Riverview Hospital, 2004-2009
• Director/Founder Cancer Genetics Program, Riverview Hospital, 2006-2009
• Director/Founder, Riverview Hospital Tumor Board, 2003-2009
• Clinical Research Protocol Committee, Riverview Hospital, 2006-2009
• Cancer Committee, Riverview Hospital, 2007-2009
• Prostate brachytherapy clinical program director 1999-2001, The Johns Hopkins Hospital

University Service

• Director of Clinical & Translational Research. Department of Radiation Oncology Loyola University Stritch School of Medicine. Maywood, IL. 2014-present
• Financial Committee. Radiation Oncology representative. Dept of Radiology, LSU School of Medicine-Shreveport. 2011.
• Chair Selection Committee for Human Oncology, University of Wisconsin School of Medicine and Public Health, 2006.
• Hospital Credentialing Committee, University of Wisconsin, 2002-03 Johns Hopkins Oncology Center Educational Committee, 1999-2000

Community Service

Formal presentations to non-medical audiences

• “Pregnancy, the abscopal effect and clues from the animal kingdom:
  Why modern cancer immunotherapy can succeed” Presentation at the Green Valley Community Performance and Art Center. Green Valley, AZ.February 2017.
• “Cancer immunobiology: A zoological Perspective” Presentation to the University of Wisconsin-Lacrosse Biology Club November 2016.
• “A brief history of the atomic age and its connection to radiation medicine” Riverview Hospital. September, 2009
• “The Nuclear Regulatory Commission and the ACMUI” Aspirus-Wausau Hospital Dosimetry and Physics staff. July 2009.
• “A brief history of the atomic age and its relevance to the people of Wisconsin Rapids.” Wisconsin Rapids Rotary Club meeting Nov 2008.
• “Cancer genetics and genetic testing for hereditary breast cancer” Presentation and discussion for the Breast Cancer Support Group of Wisconsin Rapids. Sept 2008
• “Skin cancer – prevention and treatment” A presentation for the Modern Woodmen, Wisconsin Rapids, WI, Nov 2007.
• “Questions and answers about breast cancer” Breast Cancer Support Group Wisconsin Rapids. September 11, 2007.
• “Helical tomotherapy – early history at the University of Wisconsin-Madison, evolution into TomoTherapy and recent experience at UW Cancer Center-Riverview” Wisconsin Rapids Rotary Club Meeting April, 2007
• “Helical tomotherapy – clinical implementation.” A presentation to the American Academy of Professional Coders (AAPC). Wausau WI, Sept 2006.
• “TomoTherapy comes to Wisconsin Rapids” A presentation at the UW Cancer Center-Riverview Donor’s Dinner. Aug 2006.
• “Introducing TomoTherapy” A presentation to the Riverview Hospital Board. Aug 2006.
• “What is helical tomotherapy?” A presentation to the Riverview Hospital staff. July 2006.
• “Helical tomotherapy – should we have it here in Central Wisconsin?” A presentation to the Riverview Hospital staff. May 2006.
• “Ask the doctor” A presentation for the Breast Cancer Support Group of Wisconsin Rapids, WI. Mar 2006.
• “Clinical use of amifostine as a radioprotectant” (Moderator/program coordinator) Invited presentation given by DJ Lee, MD, PhD Stevens Point, WI Aug 2005.
• “Cancer prevention.” Presented to the employees of the City of Wisconsin Rapids. Dec 2004.
• Breast cancer update. A presentation for the Breast Cancer Support Group of Wisconsin Rapids, WI. Nov 2004.
• Breast cancer update 2004. A presentation for the Breast Cancer Support Group of Wausau, WI. Oct 2004.
• Presentation for Riverview Hospital Auxiliary: The role radioisotopes in medicine. Wisconsin Rapids, Sept 2004
• Breast cancer panel: Innovations in Radiation Oncology. Presentation for the American Association of University Women. Wisconsin Rapids, Mar 2004.
• Presentation on radiation therapy and tour of the UW Cancer Center for the Laurite Chi Chapter of Beta Sigma Phi Sorority of Wisconsin Rapids. Jan 2004.
• Presentation for Rotary Club of Wisconsin Rapids: Innovations in Radiotherapy at the UW Cancer Center. Dec 2003.
• Presentation for the “I Can Cope” Lecture Series for cancer survivors in Wisconsin Rapids: Sept 2003.
• Prostate cancer screening and discussion about radiation therapy for prostate cancer. Riverview Hospital. Sept 2003.

Miscellaneous Community Service

• Wisconsin Public Radio/NRP Radio program. June 2016
  Looking To The Animal Kingdom For Cancer Treatments And Cures: An oncologist explains what we may be able to learn from the animal world that could revolutionize how we treat, and even cure, human cancer.
  http://www.wpr.org/looking-animal-kingdom-cancer-treatments-and-cures
• Voice America: Frankly Speaking About Cancer. Hosted by Kim Thiboldeaux.
  “A Search for Answers in Unlikely Places- A conversation with Dr. James Welsh.”
  Radio program. May 2016. https://www.voiceamerica.com/episode/92554/a-search-for-answers-in- unlikely-places-a-conversation-with-dr-james-welsh
• Healthy Living Chicago television promo: NIU Institute for Neutron Therapy at Fermilab November 2012. (http://livinghealthytv.com/2012/11/04/niu-institute-for-neutron-therapy-at-fermilab/)
• Prostate cancer screening. Community Baptist Church. April 2013. Joliet, IL
• Local news television interview (KTBS) regarding radioactivity and radiation concerns from the Fukushima- Daiichi nuclear plant. (2011)
• Numerous (~100) television and radio interviews and newspaper articles about research, novel clinical programs and other activities at the UW Cancer Center-Riverview. 2003-2009.
• Several (~50) public sessions, television interviews, radio interviews and newspaper articles regarding cancer prevention, cancer management, modern diagnostics and cancer research. 2003-2007.
• Monthly Wisconsin Rapids radio program: Cancer treatment and prevention updates. Aug 2003-04.

Educational Activities

1. Fermilab Ask-A-Scientist.
   • “Hadron Therapy – Corralling quarks to conquer cancer.” Aug 2013
   • “The Cancer Immunotherapy Revolution: Clues from the Animal Kingdom. Aug 2018
2. Scientific American Cruises: Bright Horizons 8. Lisbon, Portugal. Nov, 2010
   Special Guest Lecturer:
   • “Quarks and Oncogenes: Particle Physics, Molecular Oncology and Hadron Therapy in 21stCentury Cancer Treatment”
3. American Board of Radiology:
   • Maintenance of Certification task force member. 2017- present
   • Written board examination task force for Radiation Oncology Board Certification
     2004-2012. (Genitourinary, Radiobiology, Central Nervous System)
4. American College of Radiology (ACR)
   • Member, Committee on Education, Commission on Radiation Oncology. 2007-2009.
5. WI State Genetics Advisory Council: Traveling Genetics Grand Rounds Lecturer and Clinical Oncology representative. 2008-2010
6. ASTRO Education Committee
   • Education Committee 2008-2013
   • Subcommittee on Systemic Targeted Radiation Therapy (“STaRT 2”) 2007-2009
7. RSNA
   • Refresher course co-director: “Requiring a Year of Diagnostic Radiology for Radiation Oncology Residents: The Wisdom/The Reality” 2009 RSNA Scientific Program and Annual Assembly. Nov 2009.
   • Educational Committee: Radiation Oncology (Radiographics) Panelist 2010, 2011, 2012
8. Panel Member at National Meetings
   • Panel discussant: “ANS Special Presidential course on health effects of low level radiation and Implications for Fukushima Recovery”2012 American Nuclear Society Annual Meeting. Chicago. June 2012.
   • Panel discussant and course co-director: “How Much Diagnostic Radiology Training does a Radiation Oncology Resident Need?” 2009 RSNA Scientific Program and Annual Assembly. Nov 2009.
   • Panel discussant: “Management of Liver Metastases.” 51st Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) Chicago, IL. Oct, 2009
   • Panel discussant: “Targeted Radionuclide Therapy.” 50th Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) Boston, MA Sept, 2008
   • Panel discussant: “Central Nervous System, Radiosurgery, Stereotactic Body Radiation Therapy” First Sino-American Network for Therapeutic Radiology and Oncology (SANTRO) Symposium, Beijing, China. Aug 2008
   • Panel discussant: GI Malignancies. 18th Annual Meeting of the American College of Radiation Oncology. Feb 2008, Miami, FL
   • Panel discussant: Prostate cancer. 17th Annual Meeting of the American College of Radiation Oncology. Feb 2007, San Diego, CA.
9. Invited educational lectures for national and international symposia
   • “Physics of Radioisotopes” 2015 ASTRO Spring Educational Course. New Orleans, LA. March 2015.
   • “Fermilab/NIU Vision for Hadron therapy.” Joint Symposium 2013 on Carbon Ion Radiotherapy – Fostering International Collaboration between Japan and the United States in Carbon Ion Radiotherapy. Rochester, MN. May 2013.
   • “Bone-seeking Radiopharmaceuticals” Bone-seeking radiopharmaceuticals for the treatment of bone metastases from prostate cancer – A CME Symposium Held in Conjunction with the ASTRO 55th Annual Meeting. Atlanta, Georgia. Sept 2013.
   • “Future US Supply of Mo-99 through Fission-based LEU/LEU Technology” National Nuclear Security Administration 2013 Mo-99 Topical Meeting, hosted by Argonne National Laboratory. Chicago, IL. April 2013.
   • “Systemic Alpha Emitters” Presented at the 54th Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) Boston, MA 2012.
   • “Whole brain radiotherapy following stereotactic radiosurgery for brain metastases– the controversy of the year” Invited Speaker; Central Nervous System BOOST Program. 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America, Nov 2010, Chicago IL.
   • “Towards a consensus on the management of liver metastases” The 51st Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) Chicago, Ill. 2009.
   • “Helical tomotherapy – development and initial preclinical/clinical evaluation at the University of Wisconsin” Presented at 19th Annual Meeting of the American College of Radiation Oncology. Feb 2009, Las Vegas, NV
   • “The full spectrum of radiation therapy with helical tomotherapy: Clinical experience at a small cancer center in the U.S.A.” Presented at the 21st JASTRO (Japanese Society of Therapeutic Radiology and Oncology). Sapporo, Japan. Oct 2008.
   • “Radiobiology of Stereotactic Body Radiation Therapy” Presented at the First Sino- American Network for Therapeutic Radiology and Oncology (SANTRO) Symposium, Beijing, China. Aug 2008
     • Selected speaker representing ACRO, a sponsoring organization for the Inaugural SANTRO Symposium
   • “The radiopharmaceutical renaissance – A new STaRT” Presented at the 50th Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) Boston, MA Sept, 2008.
   • “Clinical cancer genetics and genetics testing for the practicing radiation oncologist” Presented at the 49th Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) Los Angeles, CA 2007
     • i. Presented as part of a SAM (self assessment module) session providing additional CME credits.
   • “US Nuclear Regulatory Commission Update – What’s new and relevant to radiation oncology and medical physics in 2007.” Presented at the 17th Annual Meeting of the American College of Radiation Oncology (ACRO). San Diego, CA. Feb 2007.
   • “Y-90 microsphere therapy for liver metastases: The USA Experience.” Second Annual Symposium on Liver Directed Microsphere Radiotherapy. Scottsdale, AZ. April 2006
   • “Therasphere and SIR-Spheres microsphere brachytherapy for malignant liver disease” (Refresher Course) Presented at the 47th Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) Denver, CO 2005.
   • “Selective Internal Radiation Therapy (SIRT) for liver metastases from colorectal adenocarcinoma. American Society for Therapeutic Radiology and Oncology (ASTRO) STaRT Symposium. Phoenix, AZ. Nov 2004.
   • “Selective internal radiation therapy (SIRT) for liver metastases.” American Pharmacy Association. Seattle, WA. Mar 2004
   • “Clinical helical tomotherapy.” Presented at the 14th Annual Meeting of the American College of Radiation Oncology (ACRO). Orlando, FL. Feb 2004.
   • “Potential pitfalls of IMRT.” Presented at the 14th Annual Meeting of the American College of Radiation Oncology (ACRO). Orlando, FL Feb 2004.
   • “Dose-rate radiobiology of large fractions.” The Second Annual Extracranial Stereotactic Radioablation Meeting. Sponsored by Indiana University School of Medicine. Halifax, Canada. June, 2003.
   • “Novel clinical applications of IMRT.” American Association of Physicists in Medicine (AAPM) Summer School: Intensity Modulated Radiation Therapy. Colorado Springs, CO. June, 2003.
   • “Integration of radiopharmaceuticals into the management of patients with bone metastases.” 2003 ACRO Meeting. Tapatio, AZ March 2003.
   • “Helical Tomotherapy.” The First Annual Extracranial Stereotactic Radioablation: Future Directions. Sponsored by Indiana University School of Medicine. Niagara Falls, Canada. May, 2002.
   • “Radiopharmaceuticals: Future Directions” Presented at ASTRO satellite symposium
     “Bone Pain Due to Cancer: Advances in Treatment.” ASTRO 42nd Annual Meeting, Boston Massachusetts, Oct. 2000.
10. Invited educational lectures for Regional Organizations
    • “Clues to a cure for cancer from the animal kingdom and beyond” Forum at Green Valley Community Performance and Art Center. Green Valley. AZ. Feb 2017
    • “Radiopharmaceuticals for bone metastases.” Chicago Radiological Society. Chicago, IL. Feb 2015.
    • “Production of Molybdenum-99 without Highly Enriched Uranium” March 2013. Midwest chapter of the Society of Nuclear Medicine and Molecular Medicine. Oakbrook, IL
    • “Hadron Therapy at Fermilab: Past, Present and Future” Midwest Chapter of AAPM. October 2013
    • “Radioisotope Therapy 2009” Radiation Therapists of Wisconsin (RTOW) Meeting. Sept 2009. Wisconsin Rapids, WI
    • “Overview of cancer genetics and clinical cancer genetics testing” Wisconsin Association of Physician Assistants (WAPA) annual meeting.” Kohler, WI. April 2007
    • “Helical tomotherapy and Image-Guided IMRT in central Wisconsin.” Wisconsin Association of Physician Assistants (WAPA) annual meeting. Kohler, WI. April 2007
    • “Cancer Research” A presentation for the Central Wisconsin Society for Clinical Laboratory Science. Wisconsin Rapids. September 13, 2007.
    • “Helical tomotherapy IG-IMRT: Experience in both a major academic facility and a small community cancer center.” Radiation Therapists of Wisconsin (RTOW) Annual Meeting. Chula Vista, WI. March 2007.
    • “Stereotactic body radiation therapy for non-small cell lung cancer.” Wausau Aspirus Lung Cancer Symposium. Wausau, WI. March 2005.
    • “Tomotherapy Update” Third Annual Baltimore ASCO Review. Baltimore, MD. June 2004
    • “Modern radiotherapy for dissecting cellulitis and related disorders.” Wisconsin Dermatology Society. Madison, WI. May, 2004.
    • “Intra-arterial interstitial brachytherapy for hepatic metastases using Y-90 tagged microspheres.” North Central Chapter of the American Association of Physicists in Medicine (AAPM). Madison, WI. May, 2004.
    • “Helical tomotherapy.” Autumn meeting of the Radiation Therapists of Wisconsin (RTOW). Wausau, WI. Nov, 2003.
    • “Radioimmunotherapy: A Clinical Update.” North Central Chapter American Association of Physicists in Medicine Spring Meeting. Wausau WI, May, 2002.
    • “Radiation Hormesis Revisited: An Evolutionary Perspective.” North Central Chapter American Association of Physicists in Medicine Spring Meeting. Wausau WI, May, 2002.
11. Visiting Professorships/Grand Rounds Presentations
    • “Clues to a cure for cancer – the abscopal effect, contagious cancer, transplanted  organs and pregnancy.” SUNY Stony Brook. July 2017.
    • “The abscopal effect, pregnancy and contagious cancer in animals: Clues to a cure for cancer? University of Arizona. Tucson, AZ. February 2017.
    • “Proton beam therapy for Non-Small Cell Lung Cancer.” Provision Proton Center Grand Rounds. Knoxville, TN. August 2016.
    • “Proton beam therapy Pros and Cons.” Approaches to Hematology/Oncology Care and Screening for Primary Care Physicians. Loyola Stritch School of Medicine. May 2016.
    • “Cancer Immunotherapy – The Long and Winding Road.” London Regional Cancer Program at Victoria Hospital Grand Rounds. March 2016.
    • “Proton Therapy Comes to Loyola.” Medical Oncology Grand Rounds. June 2015.
    • “Proton Beam Therapy – What Nurses Need to Know.” Marcella Niehoff School of Nursing at Loyola University Chicago. July 2015.
    • “Glioblastoma 2013 Update: Biomarkers” Rush Oak Park Hospital. Oak Park, IL. March 2013.
    • Visiting Professor: Northwestern School of Medicine, Chicago, IL Oct, 2012.
      • Lecture: “Modern fast neutron therapy at Fermilab.”
    • Visiting Professor: LSU Department of Physics & Astronomy, Baton Rouge, LA. June 2011
      • i. Lecture: “Parallels between particle Physics and Molecular Oncology: An intersection at Particle Therapy?”
    • Psychiatry Grand Rounds. May 2011. LSU Health Sciences Center-Shreveport. “Stereotactic radiosurgery for severe, intractable obsessive-compulsive disorder.”
    • Hematology/Oncology Grand Rounds. April 2011. Feist-Weiller Cancer Center/LSU Health Sciences Center-Shreveport. “Radiobiology of stereotactic body radiation therapy for early stage non-small cell lung cancer.”
    • Visiting Professor: Trinity School of Medicine, St Vincent and the Grenadines. October 2010; Sept 2011; Nov 2011.
    • Visiting Professor: West Virginia University/ Mary Babb Randolph Cancer Center. Aug 2009
      • Lecture: “Initial experience with IG-IMRT at the University of Wisconsin and more recent experience at the UW Cancer Center in Wisconsin Rapids” Professor: SUNY Upstate Medical Center. March 2009
      • Lecture: “The history of the Atomic Age and the Role of the ACMUI in Radiation Oncology”
      • Lecture: “Clinical helical tomotherapy: Early history at the University of Wisconsin and recent experience at the UW Cancer Center in Wisconsin Rapids”
    • Professor: Beijing Cancer Center; Beijing China. Aug 2008.
      • Lecture: “Clinical helical tomotherapy: Early history at the University of Wisconsin and recent experience at a small American community cancer center”
    • Professor, PLA 301 Hospital, Beijing, China Aug 2008
      • Lecture: “Helical tomotherapy: Development and initial clinical experience at the University of Wisconsin and recent experience at the UW Cancer Center-Riverview”
    • Professor, Air Force General Hospital, Beijing, China Aug 2008
      • Lecture: “Helical tomotherapy: Development and initial clinical experience at the University of Wisconsin and recent experience at the UW Cancer Center-Riverview”
    • Visiting Professor: NN Blokhin Russian Cancer Research Center; Russian Academy of Medicine. Moscow, Russia. May 2008.
    • Visiting Professor: University of Saskatchewan. Saskatoon, Saskatchewan, Canada. April 2008.
      • Lecture: “Clinical helical tomotherapy at the University of Wisconsin Cancer Center-Riverview” Saskatoon Cancer Center, Saskatchewan, Canada.
    • Visiting Professor, Yonsei University. Seoul, Korea. March 2008.
      • Lecture: “The history of the helical tomotherapy program at the University of Wisconsin and the present clinical applications at the UW Cancer Center- Riverview
    • Visiting Professor: Seoul National University Hospital, Seoul Korea March 2008.
    • Visiting Professor, Cheyenne Medical Center. Cheyenne, WY. July 2007
      • Grand Rounds Lecture: “TomoTherapy: History, clinical implementation and future applications.”
      • “Clinical Helical Tomotherapy at the University of Wisconsin.” U.S. Oncology Annual Meeting for New Technology. Dallas TX. Sept 2004.
    • Visiting Professor, Moncrief Cancer Center, Fort Worth TX. Sept 2004
      • Grand Rounds Lecture: “Tomotherapy.”
    • “Helical tomotherapy – a novel approach to radiation therapy developed at the University of Wisconsin.” Hess Memorial Hospital/Mile Bluff Clinic, Mauston, WI Sept 2004
    • “Helical Tomotherapy: an innovative means of delivering intensity modulated radiation therapy.” 21st Century Oncology Educational Program. Fort Meyers, FL, Sept 2002.
    • “Radiopharmaceuticals in the management of bone metastases.” Oncology Conference, Decatur Memorial Hospital, Decatur, Ill. April, 2002
    • “Innovative strategies in the management of bone metastases”
      • Grand Rounds at Sinai Hospital, Baltimore, Maryland. Sept 11, 2001
    • Visiting Professor, King Edward Hospital, Bermuda. July, 2000.
      • Grand Rounds Lecture: “The rationale for dose escalation and brachytherapy in the management of localized prostate cancer”
    • “Management of bone metastases”
      • Maryland General Hospital Grand Rounds, Baltimore, MD May, 2000
    • “Management of bone metastases”
      • Grand Rounds at Mercy Hospital, Baltimore, MD May, 2000
    • “Salvage radiation therapy for rising PSA after radical prostatectomy.”
      • Wayne State University Medical Center, Detroit, Michigan. April, 2000.
    • “Radiopharmaceuticals in the management of bone metastases” Morton Plant
      • Hospital Radiology Grand Rounds, Clearwater, Florida. June 2000.
    • “Management of post-prostatectomy rising PSA.” University of Maryland Medical Center, May 1999
    • “Radioimmunotherapy for Non-Hodgkin’s Lymphoma.” The Johns Hopkins Oncology Center Grand Rounds. January 1999.
    • “Management of bone metastases.” Walter Reed Medical Center, June 1999.
    • “Radiation Myositis.” Johns Hopkins Oncology Center Morbidity and Mortality Conference. May 1998.
    • “Radiation therapy in the management of seminoma.” The Johns Hopkins Oncology Center Grand Rounds. January 1996.
12. XII. Invited Symposium Lectures
    

    International

    • “Keynote Presentation: The ongoing revolution in cancer Immunotherapy – Clues from the most unusual places.” American Radium Society Annual Meeting. Orlando, May 2018
    • “Keynote Presentation: Proposed New Boron Neutron Capture Therapy Program at Fermilab.” ACRO CME Symposium: Neuro-radiation oncology and stereotactic radio-surgery. 11th Annual World Congress of the SBMT 2014 – Bringing Together Engineering, Art, Science and Medicine. Sydney Australia. March 2014.
    • “Endocrine Oncology – Opportunities for Novel Radiotherapy Applications” 9th Annual Sir Arnot Cato Memorial Symposium. St Vincent and Grenadines Medical Association. St Vincent. October 2010
    • “Hypofractionation in the Clinic using image-guided intensity modulated radiotherapy” Istanbul University/Italian Hospital invited lecture. Istanbul, Turkey. Feb, 2010
    • “Biological and Technical Aspects of TomoTherapy for Lung SBRT” Caribbean Oncology Outlook 2010. San Juan, Puerto Rico. August 2010
    • “The American College of Radiation Oncology – the Essential Organization for the Practicing Radiation Oncologist in the USA” The First Sino-American Network for Therapeutic Radiology and Oncology (SANTRO), Beijing, China. Aug 2008
    • “Clinical experience with helical tomotherapy in a small Tomo-only cancer center in the U.S.A.” Presented at the Japanese Symposium on TomoTherapy at JASTRO. Sapporo, Japan. Oct 2008.
    • “Origin of helical tomotherapy at the University of Wisconsin and evolution into HiART TomoTherapy of today”
    • Second Korean TomoTherapy Symposium. Seoul, Korea. March 2008.
    • “Early History of helical tomotherapy at the University of Wisconsin and clinical applications of modern TomoTherapy at UW Cancer Center-Riverview”
    • Moscow Symposium on TomoTherapy, Moscow, Russia. May 2008.

    • National

    • “Introducing certainty into the uncertainty problem of particle beam range.” National Proton Conference. Scottsdale AZ March 2018
    • “The abscopal effect, contagious cancers, transplanted cancers and pregnancy: Clues to a genuine cure for cancer?” Fermilab Colloquium. Fermilab. 23 Jul 2014
    • “Contagious Cancer, Transplanted Organs, Pregnancy and the Abscopal Effect: Clues to a Cure?” CFRI Energy Forum. Argonne National Laboratory. November, 2012
    • “TomoTherapy for SBRT” Presented at ASTRO State of the Art Techniques: IMRT, IGRT, SBRT Vendor Workshop. Las Vegas. March 2011.
    • “Experience with TomoTherapy in a small Tomo-only cancer center” Presented at ASTRO at TomoTherapy. Boston, Oct 2008.
    • “Helical tomotherapy for breast cancer: early experience at a small Tomo-only community cancer center.” ‘Meeting of the Minds’ TomoTherapy ASTRO Satellite Meeting. Los Angeles, CA. Nov 2007
    • “TomoTherapy: Extreme versatility” 4th Annual TomoTherapy North American Symposium, Madison, WI. June 2008
    • “Radiolableled phospholipids ethers: A new class of potentially important radiopharmaceuticals” Presented at the Advisory Committee on the Medical Use of Isotopes Spring Meeting, NRC Headquarters. Washington DC. April 2008.
    • “TomoTherapy: Real world wide-field and complex case applications.” TomoTherapy Users Meeting. Los Angeles, CA. Nov 2007
    • “TomoTherapy and the University of Wisconsin – A Genuine Success Story” Presented at the 2006 ASTRO UW Alumni Dinner. Philadelphia, PA. Nov 2006.
    • “Helical tomotherapy from both ends of the spectrum: Initial implementation at a major university academic center and recent experience in a small Tomo-only community cancer center.” TomoTherapy Users Meeting. Chicago IL March 2007
    • “Dose escalation and brachytherapy in the management of localized prostate cancer.” Fourth Annual Men’s Health Conference, The Johns Hopkins School of Medicine, March, 2000.
13. Invited Symposium Lectures
    

    International

    • “Keynote Presentation: The ongoing revolution in cancer Immunotherapy – Clues from the most unusual places.” American Radium Society Annual Meeting. Orlando, May 2018
    • “Keynote Presentation: Proposed New Boron Neutron Capture Therapy Program at Fermilab.” ACRO CME Symposium: Neuro-radiation oncology and stereotactic radio-surgery. 11th Annual World Congress of the SBMT 2014 – Bringing Together Engineering, Art, Science and Medicine. Sydney Australia. March 2014.
    • “Endocrine Oncology – Opportunities for Novel Radiotherapy Applications” 9th Annual Sir Arnot Cato Memorial Symposium. St Vincent and Grenadines Medical Association. St Vincent. October 2010
    • “Hypofractionation in the Clinic using image-guided intensity modulated radiotherapy” Istanbul University/Italian Hospital invited lecture. Istanbul, Turkey. Feb, 2010
    • “Biological and Technical Aspects of TomoTherapy for Lung SBRT” Caribbean Oncology Outlook 2010. San Juan, Puerto Rico. August 2010
    • “The American College of Radiation Oncology – the Essential Organization for the Practicing Radiation Oncologist in the USA” The First Sino-American Network for Therapeutic Radiology and Oncology (SANTRO), Beijing, China. Aug 2008
    • “Clinical experience with helical tomotherapy in a small Tomo-only cancer center in the U.S.A.” Presented at the Japanese Symposium on TomoTherapy at JASTRO. Sapporo, Japan. Oct 2008.
    • “Origin of helical tomotherapy at the University of Wisconsin and evolution into HiART TomoTherapy of today”
      Second Korean TomoTherapy Symposium. Seoul, Korea. March 2008.
    • “Early History of helical tomotherapy at the University of Wisconsin and clinical applications of modern TomoTherapy at UW Cancer Center-Riverview”
      Moscow Symposium on TomoTherapy, Moscow, Russia. May 2008.

    • National

    • “Introducing certainty into the uncertainty problem of particle beam range.” National Proton Conference. Scottsdale AZ March 2018
    • “The abscopal effect, contagious cancers, transplanted cancers and pregnancy: Clues to a genuine cure for cancer?” Fermilab Colloquium. Fermilab. 23 Jul 2014
    • “Contagious Cancer, Transplanted Organs, Pregnancy and the Abscopal Effect: Clues to a Cure?” CFRI Energy Forum. Argonne National Laboratory. November, 2012
    • “TomoTherapy for SBRT” Presented at ASTRO State of the Art Techniques: IMRT, IGRT, SBRT Vendor Workshop. Las Vegas. March 2011.
    • “Experience with TomoTherapy in a small Tomo-only cancer center” Presented at ASTRO at TomoTherapy. Boston, Oct 2008.
    • “Helical tomotherapy for breast cancer: early experience at a small Tomo-only community cancer center.” ‘Meeting of the Minds’ TomoTherapy ASTRO Satellite Meeting. Los Angeles, CA. Nov 2007
    • “TomoTherapy: Extreme versatility” 4th Annual TomoTherapy North American Symposium, Madison, WI. June 2008
    • “Radiolableled phospholipids ethers: A new class of potentially important radiopharmaceuticals” Presented at the Advisory Committee on the Medical Use of Isotopes Spring Meeting, NRC Headquarters. Washington DC. April 2008.
    • “TomoTherapy: Real world wide-field and complex case applications.” TomoTherapy Users Meeting. Los Angeles, CA. Nov 2007
    • “TomoTherapy and the University of Wisconsin – A Genuine Success Story” Presented at the 2006 ASTRO UW Alumni Dinner. Philadelphia, PA. Nov 2006.
    • “Helical tomotherapy from both ends of the spectrum: Initial implementation at a major university academic center and recent experience in a small Tomo-only community cancer center.” TomoTherapy Users Meeting. Chicago IL March 2007
    • “Dose escalation and brachytherapy in the management of localized prostate cancer.” Fourth Annual Men’s Health Conference, The Johns Hopkins School of Medicine, March, 2000.

    • Local/Regional Invited Talks

    • “The abscopal phenomenon, contagious cancer and other hints to the immunobiology of cancer.”
    • Emerging Technologies Symposium SEAAPM Greenville SC. Feb 2018
    • “The Abscopal Effect, Contagious Cancer, and Other Clues To A Cure for Cancer.” Chicago Area Radiation Therapists (CART) Winter Meeting January 23, 2016 Chicago, IL
    • “History of helical tomotherapy” 1st Annual Presence Regional Cancer Center Symposium. Joliet, IL. June 2013.
    • “Future developments and opportunities for neutron therapy in the USA.” Northwestern School of Medicine; Department of Radiation Oncology. June 2012.
    • “Neutron therapy at the NIU NTF at Fermilab.” Northwestern School of Medicine; Department of Radiation Oncology. June 2012.
    • “History of the Atomic Age” The Aspirus Medical Dosimetry Educational Meeting. Wausau, WI 2009
    • “Cancer genetics” Presented to the Obstetrics/Gynecology Service of Riverview Hospital, Wisconsin Rapids. WI April 2009.
    • “Radiopharmaceuticals in the management of bone metastases.” Appleton, WI, Nov 2007. “Sm-153 EDTMP in the management of bone metastases.” Chicago, Ill. June 2007.
    • “Integration of Radiopharmaceuticals into the management of bone metastases.” Madison, WI, April 2007.
    • “TomoTherapy at Riverview.” Riverview Hospital Association Medical Staff Meeting. April. 2007
    • “Radiopharmaceuticals: current and future applications for treatment of bone metastases” Madison, WI, July, 2005.
    • “Radiopharmaceuticals in the management of bone metastases: Current status and future directions” Wausau Hospital, June 2003.
    • “Clinical use of Sm-153 EDTMP and other radioisotope therapies.” Consultant’s and Sales Force Meeting and POA for Berlex Laboratories. Orlando, FL Jan 2003.
    • “Radiopharmaceuticals in the management of bone metastases: An update.” Sponsored by Georgetown University, Washington, DC May, 2002.
    • “Salvage radiation therapy for rising PSA after radical prostatectomy – Role of immunoscintigraphy in patient selection” Raleigh, North Carolina. Sept, 2000.
    • “Samarium-153 EDTMP and other radiopharmaceuticals in the management of bone metastases” Sarasota, FL June, 2000
    • “The use of radioisotopes in the management of bone metastases.” St Mary’s Hospital Continuing Medical Education Program, Richmond, VA September 25, 1999.
    • “The role of radioimmunoscintigraphy in the management of patients with rising PSA after radical prostatectomy.” Hackensack, NJ September 28, 1999.
    • “Innovations in the management of patients with skeletal metastases.” St Joseph’s Hospital Continuing Medical Education Program, Silver Spring, MD August 26, 1999.
    • “Rising PSA: A radiation oncologist’s perspective.” Meeting in Manhattan, New York, June 1999. Sponsored by Cytogen Corporation.
14. Medical School, University and Technical School Courses and Classes
    • Course Director: “Astrobiology.” An Honors Program Physics/Biological Sciences course for upper- level undergraduate students. Northern Illinois University. Winter 2014.
    • Course Director: “Oncology and Hematology” (Part of the Mechanisms of Disease Course for 5th term (second year) medical students)
      Trinity School of Medicine, St Vincent and the Grenadines.
      October, 2010
      September, 2011
      November, 2011
    • Faculty Mentor, “Zoology/Biology 151” (Introductory Biology) University of Wisconsin-Madison, 2009
    • Faculty Mentor, “Zoology/Biology 699” (Directed Study in Biology) University of Wisconsin-Madison, 2009
    • Small group session leader, “Physician, Doctor and Society” University of Wisconsin Medical School, 2002, 2003, 2004.
    • Lecturer, “Neoplasia” Course
      University of Wisconsin Medical School, 2002, 2003.
    • Lecturer, “Radiobiology” Course
      University of Wisconsin Graduate School, 2002, 2004, 2006, 2008.
    • Lecturer, “Principles and Practice of Radiation Therapy II”
      University of Wisconsin Radiation Therapy School, Feb 2003, 2004.
    • Lecturer, Clergy Cancer Residency
      University of Wisconsin Hospital, Feb 2002, 2003.
    • Course Director, “Radiation Biology”
      Radiation Therapy Technology School. The Johns Hopkins Hospital, 1999-2000.
    • Lecturer, “Radiation Biology”
      Radiation Therapy Technology School. The Johns Hopkins Hospital, 1997-1999.
    • Lecturer, “Clinical Oncology”
      Radiation Therapy Technology School. The Johns Hopkins Hospital, 1997-1998.
    • Lecturer, “Anatomy and Pathophysiology”
      Radiation Therapy Technology School. The Johns Hopkins Hospital, 1995-1997.
    • Instructor, “Anatomy and Physiology”
      State University of New York at Stony Brook School of Medicine Summer 1991.
    • Teaching Assistant, “Human Evolution” SUNY Binghamton 1984
15. Other teaching experience
    • Teacher, New Haven Public School System – Adult education teacher 1986-89
    • Teacher, New Haven Public School System – GED teacher 1988-89
16. CME Exercises: On-line educational activities:
    • ASTRO School of Radiation Oncology
      “Cancer Genetics and Genetic Testing for the Practicing Radiation Oncologist”
    • Maintenance of Certification (MOC) Online Self-assessment Module available online at: http://asro.astro.org/CourseCatalog/MOCSAMs/#radcancerbio
    • Welsh JS. Beta Radiation. The Oncologist Online CME. Available online: http://cme.theoncologist.com/
    • Welsh JS. Quarks, Leptons, Fermions, and Bosons: The Subatomic World of Radiation Therapy. The Oncologist Online CME. Available online: http://cme.theoncologist.com/
17. Teaching Awards
    • Directors Teaching Award in Clinical Science
      Johns Hopkins Oncology Center, 1999
    • Chairman’s Letter of Commendation: Resident with excellent teaching skills
      Winthrop University Hospital, 1994 – 95

    • Awards to mentored students

    • American College of Radiation Oncology Resident Travel Award. Andrew Howard, MD. 16th Annual Meeting of the American College of Radiation Oncology. Feb 2006, Orlando
    • RSNA Merit Award for “Excellence in Design” of Educational Exhibit. Afshin Forouzannia, MD. Presented at the 88th Scientific Assembly and Annual Meeting of the RSNA, 2002, Chicago Ill.
    • Formal University Mentor Committee/University Externship AdvisorMichael Lock, MD
    • University of Wisconsin Medical Physics Doctoral Committees
    • Yi Rong – Medical Physics PhD conferred 2008
    • Dinesh Tewatia- Medical Physics PhD candidate
18. Miscellaneous Educational Activities
    • Fermilab Ask-a-Scientist Program. Fermilab.

Service to Scientific/Medical Journals

• Journal of Radiation Oncology
• Editor in Chief 2018-present
• Associate Editor in Chief (2015-present)
• American Journal of Clinical Oncology
• Associate Editor (2009-present)
• Technology in Cancer Research and Treatment
• Editorial Board (2008-2016)
• Associate editor (2016-present)
• Biochemical and Biophysical Journal of Neutron Therapy & Cancer Treatments
• Editorial Board (appointed 2013)
• Radiographics
• RSNA Radiographics panel reviewer (2008-10)
• Guest Editor of special journal issues
  • Technology in Cancer Research and Treatment. 2009; 8(1)
  • Technology in Cancer Research and Treatment. 2008; 7(6)
  • American Journal of Clinical Oncology. 2006; 29(6).
  • Technology in Cancer Research and Treatment. 2006; 5(5)
• Ad Hoc Peer Reviewer
  Cancer
  Cancer Investigation
  Clinical Lung Cancer
  Clinical Prostate Cancer
  Int J Cancer
  Int J Rad Oncol Biol Phys
  JAMA
  Journal of Cancer Research and Therapeutics Lancet
  Medical Science Monitor
  Oncology
  Radiographics
  Radiotherapy & Oncology
  Urology
  World Journal of Surgical Oncology
• Advisor to the National Library of Medicine
  External reviewer of Clinical Advances in Hematology & Oncology (for PubMed inclusion)

Patents

• Biological Modulation of Radiation Therapy via differential dose-rates. Provisional patent application number: 960296.01147.P09326US02
• Phospholipid ether analogs for use in combination therapy and related methods of manufacturing. Provisional patent application no. 60/743,232.
• A novel radiopharmaceutical for diagnosis and treatment of malignant melanoma. Currently under review.

Industry Service and Consultant Activities (partial list)

• Coqui Radioisotopes
  Board of Directors
• ProTom International
  Medical Advisor 2017
• Colossal Fossils (Wausau Travelling Museum of Paleontology)
  Advisory Board
• Radion Global, Inc (2009 – 14)
  Chief Science Officer & Co-founder
• Vergent Medical
  Advisory Board (company sunsetted 2012)
• Xoft Axxent Electronic Brachytherapy Accelerated Partial Breast Irradiation Trial
  Data Safety Monitoring Board 2007-09
  Oversight Committee 2007-09
• EUSA Pharma: Advisor 2007-10.
• Myriad Genetics – Consultant 2008-09
• Cellectar, LLC: Advisory Board, 2006-07
• Cellectar, LLC: Clinical advisor. Madison, WI. September 2005. Allos Pharmaceuticals: Advisor 2005.
• Curatio CME: Advisor/consultant 2004.
• Cytogen Corporation: Advisor 1999-2004.
• Biogen/IDEC: Consultant 2004.
• Cytogen Corporation: Advisory Board. NY, NY. Apr 2004. Berlex Labs: Consultant 1999-04.
• MEDACorp: Consultant. 2000-06.
• Coulter Pharmaceuticals. Advisor 1999.

Speakers Bureaus

• Myriad Genetics 2007-2010
• TomoTherapy Inc 2007-2010
• Cytogen Corporation  1998-2006
• Genetech 2004-2005
• Berlex Laboratories 1998-2003

Research Activities

Peer review study panels

• NASA Research & Education Support Services. Space Radiation Health Panel: Radiation Carcinogenesis. Washington, D.C. August 2013.
• NASA Research & Education Support Services. Space Radiation Health Panel: Central Nervous System effects. Washington, D.C. June 2009
• NASA Research & Education Support Services. Space Radiation Health Panel: Space radiation effects. Washington, D.C. June 2007
• NASA Research & Education Support Services. Space Radiation Health Panel: Degenerative effects and Individual Susceptibility. Washington, D.C. July 2006
• U.S. Army Medical Research and Materiel Command (USAMRMC) Prostate Cancer Research Program Peer Reviewer, Tyson’s Corner, VA. July, 2000.

External Grant funding

• Project Title: A Proton Radiography System for Optimization of Proton Therapy Phase II Small Business Innovative Research (SBIR) (PI: F. Don DeJongh) Grant Number: 2 R44 CA203499-02
  Total award: $ 1,853,797
  Co-investigator. 10% salary and effort (~$140,000 ) – Active, 9/23/2016-present
• Project Title: A Proton Radiography System for Optimization of Proton Therapy Phase I Small Business Innovative Research (SBIR) (PI: F. Don DeJongh) Grant Number: 1R43CA203499-01
  FAIN: R43CA203499
  Total award: $222,602
  Co-investigator. 10% salary and effort ($17,174.00) – Active, 2015-2016
• “Improving Human Cancer Outcomes with Adaptive Helical Tomotherapy.” NIH PO1 CA889600-01-05 (PI: Minesh P. Mehta)
  Total $10,538,675.00
  Co-investigator. 50% effort and salary 2001-02
  Co-investigator. 10% effort and salary 2003-05

Presentations of Research at National/International Meetings (Oral)

• Radiation Oncology Keynote Speaker: “Perspectives in Lung Cancer – proton beam therapy. “ Lung Cancer Integrated Science-to-Practice Scientific paper oral presentation session. 101th Scientific Assembly and Annual Meeting of the Radiological Society of North America, Nov 2015, Chicago IL.
• “Novel particle accelerator approaches for heavy charged particle radiation therapy.” The 12th International Topical Meeting on the Nuclear Applications of Accelerators (AccApp ’15). (Invited; November 2015)
• “Stereotactic radiosurgery with charged particle beams.” 10th Annual World Congress of the Society for Brain Mapping and Therapeutics. Baltimore, May 14, 2013
• “Anomalous Variations of the Nuclear Decay Law: Potential Radiation Therapy Implications?” Presented at the 2013 Annual ACRO Meeting. San Antonio, TX
• “Megavoltage CT imaging: Interdisciplinary Investigations in Paleontology and Geology.” Presented at the 93rd Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2007, Chicago Ill.
  This presentation was identified by RSNA as “particularly newsworthy and embargoed for release at the time of their presentations.” Material from this presentation was featured in an online column of Scientific American Feb 1, 2008 at http://www.sciam.com/article.cfm?id=megavoltage-ct-imaging- wisconsin “Megavoltage CT Imaging Unlocks Fossil Mysteries University of Wisconsin professor tests the proficiency of cancer-care computerized tomography on geologic finds.
• “Megavoltage CT Imaging from A Helical Tomotherapy Device: Applications in Geology and Paleobiology.” Presented at the 93rd Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2007, Chicago Ill.
• “Selective internal radiation therapy (SIRT) for liver metastatases secondary to colorectal cancer: initial experience at the University of Wisconsin.” Presented at the 87th Annual Meeting of the American Radium Society Annual Meeting, Barcelona Spain, May 2005.
• “MALT lymphoma: a multi-institutional retrospective review.” Presented at the 87th Annual Meeting of the American Radium Society Annual Meeting, Barcelona Spain, May 2005.
• “Helical tomotherapy planning and treatment of patients with painful bone metastases.” Presented at the 89th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2003, Chicago Ill.
• “Helical tomotherapy for canine nasopharyngeal tumors” Presented at the International Congress for Radiation Research. Brisbane, Australia. Aug 2003.
• “Initial clinical experience with helical tomotherapy: a novel means of delivering intensity modulated radiation therapy” Presented at the 84th Annual Meeting of the American Radium Society Annual Meeting, Houston, TX. May, 2003.
• “Helical Tomotherapy With Conformal Avoidance Appears Superior To 3-D CRT And IMRT For Treatment Of Complex Tumor Volumes” Presented at the 88th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2002, Chicago Ill.
• “Helical tomotherapy with conformal avoidance appears superior to conventional radiotherapy, 3-D conformal radiation therapy and IMRT for complex tumor volumes.” Presented at the 21st Annual ESTRO Meeting. Praha, Czech Republic, Sept, 2002.
• “Radiation Therapy for Thymoma – The Johns Hopkins Hospital Experience.” Presented at the 83rd Annual Meeting of the American Radium Society Annual Meeting, Coronado, CA May, 2001.
• “Thymoma and additional neoplasms – an intrinsic association”. Presented at the 82ndAnnual Meeting of the American Radium Society Annual Meeting, London, England May, 2000
• “Effects of medical external beam photon irradiation on activity of iodine-125 brachytherapy sources” Presented at 1999 American Nuclear Society Annual Meeting. June 1999, Boston, MA
• “Stereotactic radiotherapy for Cushing’s disease and prolactinoma” Presented at LINAC Radiosurgery 1998. Lake Buena Vista Florida, December 1998.
• “Targeted radiotherapy for patients with rising PSA following radical prostatectomy guided by ProstaScint scintigraphy” Presented at the 84th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 1998, Chicago Ill.
• “Neutron beam dose profiles in tissue equivalent materials” Presented at the American Nuclear Society and European Nuclear Society Winter Meeting: International conference on the global benefits of nuclear technology and embedded topical meetings. Nov 1996 Washington, D.C.

III. Poster presentations (Presenting or first author)

• “Anomalies in the radioactive decay law: Potential Implications for Medicine” American Association of Physicists in Medicine. Nashville, TN. July 2018.
• “The Gray has got to go! Inadequacies in the current units of absorbed dose” American Radium Society Colorado Springs. May 2017.
• “Anomalous variations in nuclear decay: Potential radiation oncology implications” American Radium Society Colorado Springs. May 2017.
• “A Novel Proton Radiography System for Optimization of Proton Beam Therapy” (Presentation No : 3667 at ASTRO, Sept 12016)
• DeJongh E, DeJongh F, Rykalin V, Welsh J, Pankuch M. A Fast Monotlithic System for Proton Imaging. Presented at ACRO 2016.
• “An Ultra-Compact, Variable Energy, Continuous Wave, Fixed-Field Alternating Gradient Accelerator (FFAG) for Charged Particle Radiation Therapy” (Poster presentation at ACRO 2015)
• “FFAG Accelerators for Next-Generation Ion Beam Therapy Systems.” (poster presentation at ASTRO 2014)
• “Clinical Implications of Anomalous Variations in the Nuclear Decay Law.” Presented at the 2012 Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2012, Chicago Ill.
• “Strip bolus setup reproducibility and dose verification for chestwall irradiation with simultaneous scar boost using helical tomotherapy” American College of Radiation Oncology. Orlando Feb 2010
• “Initial clinical experience with pulsed reduced dose-rate radiotherapy on a helical tomotherapy unit.” American College of Radiation Oncology. Las Vegas Feb 2009
• “A mathematical and dosimetric analysis of the impact of edema in prostate brachytherapy.” American College of Radiation Oncology . Miami, FL Feb 2008
• “Feasibility and initial clinical experience with helical tomotherapy as a treatment for oligometastases” American College of Radiation Oncology . Miami, FL 2008
• “A dosimetric analysis of the effects of edema in prostate brachytherapy.” American Radium Society 2007. Amsterdam, Netherlands May 2007.
• “Helical Tomotherapy For Routine Breast Cancer Radiation Therapy: Feasibility And Initial Clinical Experience.” Presented at ASTRO. Los Angeles CA, 2007.
• “Scalp and Ear Sparing Whole Brain Radiation Therapy Using Helical Tomotherapy.” Presented at ASTRO. Los Angeles CA, 2007.
• “Dosimetric consequences of prostate edema when using Cesium-131 brachytherapy sources.” American Brachytherapy society 2007. Chicago, Ill. May 2007.
• “Periodic irradiation from the cosmos over geologic history: potential biological impact” Presented at the Radiation Research Society Annual Meeting, Denver, CO Sept 2005.
• “Variations in biologically effective background radiation over Earth’s history.” Presented at the 86th Annual Meeting of the American Radium Society Annual Meeting, Barcelona Spain, May 2005.
• “Reduced toxicity re-irradiation techniques: pulsed low dose-rate and GRID radiotherapy.” Presented at the 90th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2004, Chicago Ill.
• “Immunobiology of low-dose total body irradiation for cancer therapy.” Presented at the 89th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2003, Chicago Ill.
• “Helical tomotherapy: 3D set-up verification and treatment implementation in dogs with spontaneous nasopharyngeal tumors.” Presented at the 89th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2003, Chicago Ill.
• “Megavoltage CT imaging for adaptive helical tomotherapy of lung cancer.” Presented at the  45th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO). Salt Lake City, Utah. Oct 2003.
• “Geomagnetic polarity reversals as a mechanism for the punctuated equilibrium model of biological evolution” Presented at the International Congress for Radiation Research. Brisbane, Australia. Aug 2003.
• “Dosimetric consequences of breast edema during external beam radiation therapy.” Presented at AAPM. San Diego, CA. Aug 2003.
• “Conformal avoidance radiotherapy with helical tomotherapy for lymphoid malignancies: A new mantle.” Presented at the 39th Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago, IL. June 2003.
• “Breast edema during radiotherapy can result in underdosing.” Presented at the 84rd Annual Meeting of the American Radium Society Annual Meeting, Houston, TX. May, 2003.
• “Radiation dose-rate: An overlooked confounding variable?” Presented at the 84rd Annual Meeting of the American Radium Society Annual Meeting, Houston, TX. May, 2003.
• “Helical Tomotherapy: an innovative technology and approach for the delivery of intensity modulated radiotherapy.” Presented at the 88th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2002. Chicago Ill.
• “Radiation dose-rate considerations with IMRT” Presented at the 21st Annual ESTRO Meeting. Praha, Czech Republic, Sept 2002.
• “Helical Tomotherapy: an innovative technology for delivery of intensity modulated radiotherapy.” Presented at the 21st Annual ESTRO Meeting. Praha, Czech Republic, Sept, 2002.
• “Implanted gold fiducial markers for guiding conformal external beam radiation therapy.” Presented at the 87th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2001, Chicago Ill.
• “Fractionated Low Dose-Rate Whole Abdominal Irradiation For Recurrent Malignancy.” Presented at the 83rd Annual Meeting of the American Radium Society Annual Meeting, Coronado, CA May, 2001
• “Radiotherapy for Intractable Dissecting Cellulitis of the Scalp.” Presented at the 86th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2000, Chicago Ill.
• “Short-term results and quality of life issues after I-125 interstitial prostate brachytherapy in a community hospital setting” Presented at the 84th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 1998, Chicago Ill.
• “Intracystic P-32 brachytherapy: A proposed treatment protocol and the influence of iodine on P-32 bremsstrahlung” Presented at the American Brachytherapy Society Annual Meeting May 1998, Albuquerque, New Mexico.

Additional posters (Not presenter or first author)

• DeJongh E, DeJongh F, Rykalin V, Pankuch M, Welsh JS. “A Proton Radiography System for Optimization of Proton Therapy” (PTCOG-NA. Nashville, TN. October 2016)
• DeJonghE,DeJonghF,RykalinV,WelshJ,PankuchM. ProtonResidualRangeReconstruction andImpactonDosetotheTargetObjectinaProtonImagingSystem. PosterpresentedatPTCOG 2016, Prague, Czech Republic.
• DeJongh E, DeJongh F, Rykalin V, Welsh J, Pankuch M. A Fast Monotlithic System for Proton Imaging. Poster presented at PTCOG 2016, Prague, Czech Republic.
• DeJongh F, Rykalin V, Welsh J, Pankuch M. A Fast Monotlithic System for Proton Imaging. Poster presented at PTCOG 2015

Publications

Abstracts and Meetings Transactions

• James S. Welsh, Ephraim Fischbach. Anomalous Variations in Nuclear Decay: Potential Radiation Oncology Implications. Int J Radiat Oncol Biol Physics. Volume 98, Issue 2, Supplement, 1 June 2017, Page E44
• Chary Rangacharyulu, Christine K. Roh, Ramy Tannous, James S. Welsh. The Gray Has Got to Go! Inadequacies in the Current Units of Absorbed Dose. Int J Radiat Oncol Biol Physics. Volume 98, Issue 2, Supplement, 1 June 2017, Page E44
• JS Welsh, F. DeJongh, Victor Rykalin, E. DeJongh. A Novel Proton Radiography System for Optimization of Proton Beam Therapy. International journal of radiation oncology, biology, physics 96(2S):E680-E681. October 2016.
• JS Welsh, E. DeJongh, F. DeJongh, Victor Rykalin. A Proton Radiography System for Optimization of Proton Therapy. Journal of Radiation Oncology. June 2016, Volume 5, Issue 2, pp 109-130
• F. DeJongh, V. Rykalin, E. DeJongh, J. Welsh. A Proton Radiography System for Optimization of Proton Therapy. Int J Particle Ther. Aug 2016. Page 256. DOI 10.14338/IJPT.16-PTCOG-1.1
• E. DeJongh, F. DeJongh ,V. Rykalin, J. Welsh. Proton Residual Range Reconstruction and Impact on Dose to the Target Object in a Proton Imaging System. Int J Particle Ther. Aug 2016. Page 260. DOI 10.14338/IJPT.16-PTCOG-1.1
• Carol Johnstone and James Welsh. An Ultra-Compact, Variable Energy, Continuous Wave, Fixed-Field Alternating Gradient Accelerator (FFAG) for Charged Particle Radiation Therapy” J Radiat Oncol (2015) 4:218
• JS Welsh, F. DeJongh, R. Schulte, C. Johnstone. FFAG Accelerators for Next-Generation Ion Beam Therapy Systems. Int J Radiat Oncol Biol Phys 2014 (ASTRO)
• C. Johnstone, F. DeJongh, R. Schulte, G. Coutrakon, J. Welsh. Technologies for Next- Generation Proton and Ion Beam Therapy Systems. Proc IEEE. Abstr #HT1-1, p79; 2013. (Available at: http://www.nss-mic.org/2013/program/ListProgramDB.asp?session=HT1#)
• Welsh JS, Javorsek D, Buse G, Fischbach E, Flores N, Gruenwald J, Jenkins J, Lee R, Mundy D, Sturrock P Anomalous Variations of the Nuclear Decay Law: Potential Radiation Therapy Implications? Abstract #49, page 2. Proc ACRO 2013.
• Welsh J, Javorsek D, Buse G, Fischbach E, Flores N, Gruenwald J, Jenkins J, Lee R, Mundy D, Sturrock P Clinical Implications of Anomalous Variations in the Nuclear Decay Law. Radiological Society of North America 2012 Scientific Assembly and Annual Meeting; November 27- December 2, 2011 Chicago IL. rsna2012.rsna.org/search/event_display.cfm?em_id=12043885 Accessed January 16, 2013.
• J.S. Welsh Evidence Supporting the Assertion That the Current Definition of Medical Events Is Imperfect for Prostate Permanent Implant Brachytherapy. Int J Radiat Oncol Biol Phys. 2012; Vol. 84, Issue 3, Supplement, page S389.
• FL Ampil, G Caldito, JS Welsh, C Previgliano, RG Baluna. “Emergency” Palliative Radiotherapy for Superior Vena Caval Obstruction by Lung Cancer: Is Timing Crucial? Proc RSNA 2011.
• Nag S, Demanes DJ, Hagan M, Rivard MJ, Thomadsen BR, Welsh JS, Williamson JF. How to define medical events for brachytherapy. Am J Clin Oncol. 2011
• Y Rong, B Paliwal, J Welsh. Physics Commissioning in Xoft Axxent® Electronic Brachytherapy (eBx) for the Primary Treatment of Non-Melanoma Skin Cancer. Med Physics (Proc AAMP 2010)
• Rong Y, Paliwal B, Welsh J. Strip bolus setup reproducibility and dose verification for chestwall irradiation with simultaneous scar boost using helical tomotherapy. Am J Clin Oncol 33(2); 213. Feb 2010.
• Yi Rong, Jarrod Adkison, Bhudatt R Paliwal, James S Welsh. Evaluation of the Strip Bolus Setup for Chest Wall Irradiation with Concurrent Scar Boost using Helical Tomotherapy. Proc Am Radium Soc. 2010.
• Rong Y, Tang G, Welsh J, Paliwal B, Yu C. Helical tomotherapy vs. Single-arc intensity modulated arc therapy (IMAT): A collaborative dosimetric comparison between two institutions. Int J Radiat Oncol Biol Phys (Proc 51st Ann ASTRO Meeting). Abstr S664. 75(3); 2009.
• Jarrod Atkison, MD; Wolfgang Tomé; Songwon Seo; Ian H. Robins; Karl Rassmussen; James S. Welsh; Peter A. Mahler; Steven P. Howard, MD, PhD. Reirradiation of large volume recurrent high grade glioma with pulsed reduced dose-rate radiation Abstr 451. Proc Soc Neuro Oncol. 2009
• Y Rong, S Howard, J Welsh, “Pulsed reduced dose-rate radiotherapy using a helical tomotherapy unit”, Med. Phys. 36: 2710 (2009)
• Rong Y, Tang G, Welsh J, Paliwal B, Yu C. A collaborative dosimetric comparison for helical tomotherapy and single-arc intensity modulated arc therapy (IMAT) between two institutions. Radiotherapy & Oncology. 92(S1):S24 (ESTRO abstract 59); 2009.
• Yi Rong, James Welsh. Megavoltage CT simulation as an alternative to conventional CT when metallic artifact is severe: Comparison of two TomoTherapy planning methods. Am J Clin Oncol (ACRO proceedings) Feb 2009
• Yi Rong, Steven Howard, James Welsh. Initial clinical experience with pulsed reduced dose-rate radiotherapy on a helical tomotherapy unit. Am J Clin Oncol Feb 2009 (ACRO proceedings)
• Jarrod Adkison, Songwon Seo, Wolfgang Tome, Karl Rassmussen, Henry Robins, James Welsh, Steven Howard. Prognostic Factors For Large Volume Recurrent Glioma Treated With Pulsed Reduced Dose-Rate Radiation Therapy. Am J Clin Oncol Feb 2009 (ACRO proceedings)
• Welsh JS, Limmer JP, Limmer D. A mathematical and dosimetric analysis of the impact of edema in prostate brachytherapy. Am J Clin Oncol 2008 – Vol 31; 6
• Welsh JS, Jaradat H, Davis R. Feasibility and initial clinical experience with helical tomotherapy as a treatment for oligometastases. American Journal of Clinical Oncology: December 2008 – Volume 31 – Issue 6 – pp 606-622.
• Welsh JS, Limmer JP. Megavoltage CT imaging: Interdisciplinary Investigations in Paleontology and Geology. Radiology (Proc RNSA) 2008.
• Welsh JS, Limmer JP. Megavoltage CT Imaging from A Helical Tomotherapy Device: Applications in Geology and Paleobiology. Radiology (Proc RNSA) 2008.
• E Soisson, M Mehta, P Harari, M Ritter, J Welsh, D Khuntia, R Patel, Bpaliwal, W Tome, H Jaradat, J Limmer, L Schubert, D Westerly, A Gutierrez, S Bentzen, R Jeraj, T Mackie. Five years of experience with helical tomotherapy. Radiotherapy and Oncology 84, Suppl 2:S10; 2007.
• Welsh JS, Limmer JP. A dosimetric analysis of the effects of edema in prostate brachytherapy with Cs-131, Pd-103 and I-125. Oncology. Vol 21, No 5 Suppl 2: p 23; 2007
• D. Henrich, J. Buskerud, J. P. Limmer, V. Mullins, R. Adkins, J. S. Welsh. Helical Tomotherapy For Routine Breast Cancer Radiation Therapy: Feasibility And Initial Clinical Experience. Int J Radiat Oncol Biol Phys. 2007; 6; 3S: S236-237 (asbtr 2060).
• J. P. Limmer, J. Buskerud, D. Henrich, R. Adkins, V. Mullins, J. S. Welsh. Scalp and Ear Sparing Whole Brain Radiation Therapy Using Helical Tomotherapy. Int J Radiat Oncol Biol Phys. 2007; 6; 3S: S729 (asbtr 2942).
• Tome WA, Atkinson J, Robbins HI, Rassmussen K, Welsh JS, Mahler P, Howard SP. Pulsed reduced rate radiotherapy: A novel retreatment strategy in the management of large volume recurrent glioma. Int J Radiat Oncol Biol Phys. 2007; 6; 3S: S241-242 (asbtr 2069).
• Welsh JS, Patel RR, Khuntia D, Limmer J. Impact of prostate edema on Cs-131 brachytherapy. Brachytherapy, Volume 6, Issue 2, Page 104; 2007.
• RG Selwyn, MA Avila-Rodriguez, RJ Nickles, BR Thomadsen, JS Welsh, JA Hampel. A new positron-emitting microsphere to assess 90Y microsphere distribution in vivo and to facilitate dosimetry for Selective Internal Radiation Therapy (SIRT). J Nucl Med. 2007; 48 (Supplement 2):308P
• Selwyn RG, Rodriguze MA, Nickles RJ, Thomadsen B, Welsh JS. Positron-emitting microspheres for assessing dose distributions in liver microsphere brachytherapy. Brachytherapy, Volume 6, Issue 2, Pages 112-112; 2007.
• R Selwyn, C Jaskowiak, R Nickles, J McDermott, J Welsh, L DeWerd, and B Thomadsen. The Development and Validation of an Image-Based Dosimetry System for 90Y Microspheres Used to Treat Hepatic Tumors. Medical Physics. 34(6):2506; 2007.
• Gregory M. Richards, M.D., Wolfgang Tomé, Ph.D., H. Ian Robins M.D., Ph.D., James A. Stewart M.D., Karl Rassmussen B.S., James S. Welsh M.S., M.D., Peter A. Mahler, M.D., Ph.D., and Steven P. Howard, M.D., Ph.D. Pulsed reduced dose-rate radiotherapy: A novel re-irradiation strategy for recurrent breast cancer. Proc ACO Breast symposium 2007.
• Welsh JS, Limmer JP. A dosimetric effects of edema in prostate brachytherapy with Cs- 131, Pd-103 and I-125. (P2); Oncology. ARS Proceedings 2007.
• Howard SP, Welsh J, Robbins I, Tomé WA. Modulation of dose rate effects to minimize normal neural tissue toxicity while maximizing tumor control probability. 7th International Stereotactic Radiosurgery Society Congress, Brussels, Belgium, 2005.
• Hui S, Gerbi B, Kapatoes J, Olivera G, Henderson D, Manon R, Mackie T, Welsh J, and Fowler J. Feasibility Study of Helical Tomotherapy for Total Body and Total Marrow Irradiation. Med. Phys. 32, 1902 (2005)
• Welsh JS. Periodic irradiation from the cosmos over geologic history: potential biological impact. (Radiation Research Society meeting transactions 2005)
• Welsh JS, Welsh WF. Variations in biologically effective background radiation over Earth’s history. Cancer Journal. 2005 In press.
• J. Welsh, Huie M, Greiner L, Thomas J, Mulkerin D, Smith R, McDermott J, Neider R, Bianco J, Holen K. Selective internal radiation therapy (SIRT) for liver metastatases secondary to colorectal cancer: initial experience at the University of Wisconsin. Cancer Journal 2005 In press.
• Howard A, Reding D, Auchter R, Welsh JS. MALT lymphoma: a multi-institutional retrospective review. Cancer Journal 2005 In press.
• Welsh JS, Buskerud J, Limmer J, Henrich D, Barton D, Tome W, Howard SP. Reduced Toxicity Re-irradiation Techniques: Pulsed Low-dose-rate and Grid External Beam Radiation Therapy. RSNA Scientific Assembly and Annual Meeting Program, 2004.
• Orton N, Jaradat H, Welsh JS, Tome W. Whole scalp irradiation using helical tomotherapy. Rad Ther Oncol (Proc ESTRO). 2004.
• Huie, M.; Greiner, L.; Thomas, J.; Mulkerin, D.; Smith, R.; Welsh, J.; McDermott, J.; Neider, R.; Bianco, J.; Holen, K. Institutional series of selective internal radiation therapy (SIRT) for liver predominant metastatic colorectal cancer (MCRC): 3665. Journal of Clinical Oncology. 22 Sup 14:285s, July 15, 2004.
• Welsh JS, Forouzannia A, Hui S, Kapatoes J, Mackie TR, Ritter MA. Helical tomotherapy planning and treatment of patients with painful bone metastases. RSNA Scientific Assembly and Annual Meeting Program, 2003. p 478.
• Welsh JS. Immunobiology of low-dose total body irradiation for cancer therapy. RSNA Scientific Assembly and Annual Meeting Program, 2003. p 718.
• Welsh JS, Bradley K, Manon R, Lock M, Patel R, Ruchala K, Mackie TR, Mehta M. Megavoltage CT imaging for adaptive helical tomotherapy of lung cancer. Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2 Suppl):S429.
• Zhang T, Keller H, Jeraj R, Manon R, Welsh J, Patel R, Fenwick J, Mehta M, Mackie TR, Paliwal B. Breathing synchronized delivery – a new technique for radiation treatment of the targets with respiratory motion. Int J Radiat Oncol Biol Phys. 2003; 57(2 Suppl):S185-6.
• T. Zhang, H. Keller, Robert Jeraj, R. Mannon, J. Welsh, R. Patel, M. Mehta, T.R. Mackie, B. Paliwal, “Radiation treatment of the targets with respiratory motion using Breathing Synchronized Delivery (BSD) : a feasibility study”, V: Abstracts, (Radiotherapy & Oncology, 0167-8140, Vol. 68), ESTRO Conference, 13-18.9.2003, Geneve, Elsevier, 2003, vol. 68, str. S74, 2003. [COBISS.SI-ID 18016807]
• Welsh J, Turek M, Forrest L. “Helical tomotherapy for canine nasophayrngeal tumors” Proc 12th Int Congress Rad Res. 2003; 146(abstr PP14/0447).
• Lock ML, Bylsma M, Hui S, Welsh JS, Thurman S, Mackie TR. Beast edema in tangential irradiation of the breast: when does edema cause a clinically significant decrease in dosimetric parameters? Proc 12th Int Congress Rad Res. 2003; 259(abstr PO5/1268).
• Welsh JS, Welsh AL, Welsh WF. Geomagnetic polarity reversals as a mechanism of the punctuated equibilbrium model of biological evolution. Proc 12th Int Congress Rad Res. 2003; 199(abstr PO214/1085).
• J Kapatoes, K Ruchala, G Olivera, L Forrest, M Turek, T Mackie, J Welsh, H Jaradat, J Balog, W Lu, R Jeraj, P Reckwerdt. Dose Verification for Image-Guided Radiotherapy. Medical Physics, Vol. 30, No. 6, June 2003.
• K Ruchala, G Olivera, J Kapatoes, J Balog, J Welsh, W Lu, R Jeraj, T Mackie. Clinical Megavoltage CT — Imaging Scenarios From Routine to Extreme. Medical Physics, Vol. 30, No. 6, June 2003.
• Hui S, Lock M, Thurman S, Limmer J, Barton D, Mackie TR, Welsh JS. Dosimetric consequences of breast edema during external beam radiation therapy. Medical Physics, Vol. 30, No. 6, June 2003.
• Mehta M, Tome W, Scrimger R, Welsh J, Chapell R, Fowler J, Mackie T. Helical tomotherapy: An innovative technological radiation therapeutic approach to lung cancer. Lung Cancer. 2003; 41 (S3):S67-68.
• Bradley K, Manon R, Patel R Henderson D, Wiederholt P, Mehta M, Welsh J. Megavoltage CT imaging for image-guided lung cancer IMRT. Lung Cancer. 2003; 41 (S2):S10-11.
• Welsh JS, Tannehill S, Olivera G, Bradley K, Lock M, Hui S, Kapatoes J, Kahl B, Howard SP, Mackie TR. Conformal avoidance radiotherapy with helical tomotherapy for lymphoid malignancies: A new mantle. Proceedings of the 39th Ann ASCO Meeting. Vol 22; p593 (abstr # 2385); 2003.
• Welsh JS, Benedict S, Fowler JP. Dose-rate radiobiology of large fractions. Proceedings of the 2nd Annual Extracranial Stereotactic Radioablation. May, 2003.
• Welsh, James S. MS, MD; Hui, Susanta PhD; Lock, Michael MD; Limmer, Jeffery MS; Barton, Darryl MD; Thurman, Sarah A. MD Breast Edema during Radiotherapy Can Result in Underdosing: P024. Cancer Journal. 9(6):507-508, November/December 2003
• Welsh, James S. MS, MD; Fowler, Jack P. PhD; Tome, Wolfgang PhD; Howard, Steven P. MD, PhD Dose-Rate in IMRT: An Overlooked Confounding Variable?: P025. Cancer Journal. 9(6):508, November/December 2003
• Welsh, James S. MS, MD, et al. Initial Clinical Experience with Helical Tomotherapy: A Novel Means of Delivering Intensity Modulated Radiation Therapy. Cancer Journal. 9(6):488-489, November/December 2003.
• Welsh J, Mehta M, Olivera G, Forrest L, Forouzannia A, Kapatoes J, Ruchala K, Lu W, Reckwerdt P, Mackie T. Helical Tomotherapy: An innovative technology for delivery of Intensity Modulated Radiotherapy. Radiotherapy and Oncology. 64 (suppl 1) S211; 2002.
• Welsh J, Fowler J, Burkammer M, Mehta M, Howard SP. Radiation dose-rate considerations with Intensity Modulated Radiotherapy. Radiotherapy and Oncology 64 (suppl 1) S312; 2002.
• Welsh J, Olivera G, Hui S, Henderson D, Forouzannia A, Kapatoes J, Ruchala K, Lu W, Reckwerdt P, Mackie TR. Helical Tomotherapy With Conformal Avoidance Appears Superior To 3-D CRT And IMRT For Treatment Of Complex Tumor Volumes. Radiotherapy and Oncology. 64 (suppl 1) S124; 2002.
• Ruchala K, Olivera G, Forrest L, Mehta M, Kapatoes J, Welsh J, Mackie T. Megavoltage CT for Image-guided radiotherapy. Radiotherapy and Oncology. 64 (suppl 1) S12; 2002.
• Forouzannia A, Mackie TR, Mehta M, Welsh J. Helical Tomotherapy: An Innovative Technology and Approach for the Delivery of Intensity Modulated Radiation Therapy. Radiology. 225(P):711; 2002.
• Welsh J, Olivera G, Hui S, Henderson D, Forouzannia A, Tome W, Kapatoes J, Ruchala K, Lu W, Reckwerdt P, Ritter M, Mackie TR. Helical Tomotherapy With Conformal Avoidance Appears Superior To 3-D CRT And IMRT For Treatment Of Complex Tumor Volumes. Radiology. 225(P):360; 2002.
• Welsh J. Helical Tomotherapy: An innovative technology for delivery of Intensity Modulated Radiotherapy. Proceedings of Extracranial Stereotactic Radioablation: Future Directions, May, 2002
• Tome W, Welsh JS, Howard SP. Fractionated low dose rate irradiation: A unique application of tomotherapy. Proceedings of the 6th International Conference on Dose, Time and Fractionation in Radiation Oncology: Biological and physical basis of IMRT and Tomotherapy. Page 48. Sept, 2001.
• Welsh JS, Shickell DL, Borzillary S, Berta C, Sam C, Myers L, and Detorie N. Implanted gold fiducial markers for guiding conformal external beam radiation therapy. Radiology. 221(suppl) 171; 2001.
• Merideth RF, Leigh BR, Wiseman GA, Kornmehl EM, Raubitschek AA, Welsh JS, Levy RL, Terry LN, Zhang C, White CA. Zevalin Radioimmunotherapy is Effective for Patients with Bulky Non-Hodgkin’s Lymphoma. Int J Rad Oncol Biol Phys. 2001
• Kuhn T, Wilkins KB, Patel M, Bulkley G, Welsh JS. Radiation Therapy for Thymoma – The Johns Hopkins Hospital Experience. The Cancer Journal. 7:522-3;2001.
• Song DY, Abrams RA, Jones RJ, Welsh JS, Haulk TL, Korman LT. Phase I study of low dose rate, local regional irradiation with Cytoxan-TBI and bone marrow transplantation for patients with chemotherapy resistant non-Hodgkin’s or Hodgkin’s lymphoma. The Cancer Journal. 7,549;2001
• Welsh J, Howard S. Fractionated Low Dose-Rate Whole Abdominal Irradiation For Recurrent Malignancy. The Cancer Journal. 47-8; 2001
• Song DY, Lawrie WT, Abrams RA, Kafonek DR, Bayless TM, Welsh JS, DeWeese TL. Acute and late radiotherapy toxicity in patients with inflammatory bowel disease. Int J Radiat Oncol Biol Phys. 2001.
• Welsh JS, Tena L, Brenner M. “Radiotherapy for Intractable Dissecting Cellulitis of the Scalp.” Radiology. 217(P),149;2000.
• Shickell D, Asrari FA. Welsh J. “Three-dimensional evaluation of nodal coverage with conventional radiotherapy.” Radiology. 217(P),441;2000.
• Kornmehl E, Wiseman G, Sparks R, Leigh B, Erwin W, Silverman D, Podoloff D, Welsh J, Dunn W, Gordon L, Grillo-Lopez A, White C. “Zevalin Radioimmunotherapy (RIT) For B- Cell Non-Hodgkin’s Lymphoma (NHL): Biodistribution and Dosimetry Results.” Proc 42ndAnn Meeting ASTRO (Int J Radiat Oncol Phys 2000)
• Kornmehl EM, Wiseman GA, Sparks RB, Leigh BR, Erwin WD, Silveman DA, Podoloff DA,Welsh J, Dunn WL, Gordon LI, Grillo-Lopez AJ, White CA. Zevalin radioimmunotherapy for relapsed or refractory B-cell non-Hodgkin’s lymphoma: Interim clinical and dosimetry findings support a weight-adjusted dosing schedule. Proc 42nd Ann Meeting ASTRO 2000 (Int J Radiat Oncol Phys)
• Welsh J, Bass-Wilkins K, Bulkley G, Green R, Askin F, Howard S. “Thymoma and neoplasia – an intrinsic association.” The Cancer Journal, Scientific American. March/April 2000.
• Welsh J, Chin B, Petronis J, Howard S, DeWeese T. “Targeted radiotherapy for patients with rising PSA following radical prostatectomy guided by ProstaScint scintigraphy.” Radiology 209:286; 1998.
• Welsh J, Thurman S, Poussin H. “Short-term results and quality of life issues after I-125 interstitial prostate brachytherapy in a community hospital setting.” Radiology 209:589; 1998.
• Chin B, Welsh J, DeWeese T, Partin A, Petronis A. “Indium-111 labeled CYT 356 (Prostascint) scintigraphy may alter therapeutic management for patients with rising PSA values after radical prostatectomy.” Journal of Nuclear Medicine. 39:149; 1998
• Welsh J, Yang N, Wharam M, Civelek A, Williams J. Intracystic P-32 brachytherapy: A proposed treatment protocol and the influence of iodine on P-32 bremsstrahlung. Proceedings of the American Brachytherapy Society Annual Meeting.1998.
• Mayer R, Welsh J, Mayer-Chen H. Focused neutron beam dose deposition profiles in tissue equivalent materials: a pilot study for BCNT. Int Soc for Optical Engineering conference proceedings (SPIE). (Presented at the 5th International Conference on Applications of Nuclear Techniques, Crete, Greece June 1996).
• Yang N, Welsh J, Williams J, Civelek A. Effects of iodine on P-32 bremsstrahlung: Potential image enhancing tool. Medical Physics. Vol. 25, No. 7, Part 1:A216; 1998.
• Bass K, Green R, Patel M, George S, Diener-West M, Welsh J, Howard S, Askin F, Bulkley G. “Clinical and pathologic predictors of survival in patients with thymoma.” Transactions of the 1999 American Surgical Association Meeting (Annals of Surgery).

Peer reviewed manuscripts and letters

• Engel S, Lischalk JW, Barry P, Hopkins S, Welsh JS, Fernandez E, Mundt AJ. Radiation Oncology Resident Mentorship: Results of a Resident-Coordinated Mentorship Program. J Am Coll Radiol. 2017 Aug 30. pii: S1546-1440(17)30867-0. doi: 10.1016/j.jacr.2017.07.011.
• Emami B, Roeske J, Block A, Welsh JS. The Emami paper 25 years later. J Radiat Oncol (2017) 6: 1. doi:10.1007/s13566-017-0295-6
• Hentz C, Welsh JS. Androgen Deprivation Therapy and Subsequent Dementia. JAMA Oncology. 2017 May 4. doi: 10.1001/jamaoncol.2016.5854. [Epub ahead of print]
• Sura K, Lischalk JW, Leckie J, Welsh JS, Mundt AJ, Fernandez E. Modern radiation oncology residency contouring education experience: Outcomes from a recent webinar-based contouring
• Mortazavi S, Bevelacqua JJ, Corrice L, Dobrzyński L, Feinendegen LE, Miller ML, Sacks B, Ulsh B,Pennington CW, Welsh J, Doss M. Comment on “Chromosomal Aberrations in Large Japanese Field Mice (Apodemus speciosus) Captured Near Fukushima Dai-ichi Nuclear Power Plant”. Environ Sci Technol. 2017 Jul 18;51(14):8196-8197. doi: 10.1021/acs.est.7b01900.
• Sura K, Lischalk JW, Leckie J, Welsh JS, Mundt AJ, Fernandez E. Webinar-Based Contouring Education for Residents. J Am Coll Radiol. 2017 Aug;14(8):1074-1079.e3. doi: 10.1016/j.jacr.2017.03.013. Epub 2017 May 24.
• Siegel JA, Sacks B, Pennington CW, Welsh JS. Dose Optimization to Minimize Radiation Risk for Children Undergoing CT and Nuclear Medicine Imaging Is Misguided and Detrimental.
• Emami B, Roeske J, Block A, Welsh JS. The Emami paper 25 years later. J Radiat Oncol (2017) 6: 1. doi:10.1007/s13566-017-0295-
• Hentz C, Welsh JS. Androgen Deprivation Therapy and Subsequent Dementia. JAMA Oncology. 2017 May 4. doi: 10.1001/jamaoncol.2016.5854. [Epub ahead of print]
• Sura K, Lischalk JW, Leckie J, Welsh JS, Mundt AJ, Fernandez E. Modern radiation oncology residency contouring education experience: Outcomes from a recent webinar-based contouring approach. Journal of the American College of Radiology. 2017 May 24. pii: S1546-1440(17)30321-6. [Epub ahead of print]
• Block AM, Scott R. Silva SR, Welsh JS. Low-dose Total Body Irradiation: An Overlooked CancerImmunotherapy Technique. Journal of Radiation Oncology (in press)
• Welsh JS, Sacks B, Siegel JA. Time to Eliminate LNT: The NRC Needs to Adopt LT andEliminate ALARA. Nuclear Medicine and Biomedical Imaging. 2017; 2(1):1-5. DOI: 10.15761/NMBI.1000118
• Siegel JA, Sacks B, Pennington CW, Welsh JS. Response to Comments by Drs Hamaoka andBeyea on The Birth of the Illegitimate Linear No-Threshold Model: An Invalid Paradigm for Estimating Risk Following Low-dose Radiation Exposure. 2017; 40(1):106-07.
• Welsh JS and Traum T. On naked mole rats and cancer. Vet Pathol November 2016. 53: 1264-1265, doi:10.1177/0300985816646434
• Welsh JS (2016) Commentary: Are Children Like Werewolves? Full Moon and Its Association withSleep and Activity Behaviors in an International Sample of Children… Not all full moons are created equal! Front. Pediatr. 4:94. doi: 10.3389/fped.2016.00094
• Socol Y, Welsh JS. Changing Attitude Toward Radiation Carcinogenesis and Prospects for Novel Low-Dose Radiation Treatments. Technol Cancer Res Treat. Technol Cancer Res Treat. 2016 Dec; 15(6):732-736.
• Siegel JA, Pennington CW, Sacks B, Welsh JS. (2016) Rectifying Radon’s Record: An Open Challenge to the EPA. Int J Radiol Imaging Technol 2:014.
• Stang, K., Silva, S., Block, A.M., Welsh JS. The integration of radiation therapy and immunotherapy in melanoma management. J Radiat Oncol (2016) 5: 131. doi:10.1007/s13566-016-0256-5
• Cutler JM and Welsh JS. Leukemia and Ionizing Radiation Revisited. Journal of Leukemia. 2015, 3(4):1-2.
• Cuttler JM, Garzon P, Mitchel REJ, Feinendegen LE, Sakamoto K, Welsh JS (2016) Adjuvant Therapy for Resected Exocrine Pancreatic Cancer by Half-Body Low-Dose Irradiation. J Cancer Clin Trials. 1: 105. doi:10.4172/jcct.1000105
• Siegel JA, Pennington CW, Sacks B, Welsh JS. The Birth of the Illegitimate Linear No-Threshold Model: An Invalid Paradigm for Estimating Risk Following Low-Dose Radiation Exposure. American Journal of Clinical Oncology (2015 Nov 3. [Epub ahead of print])
• Welsh JS and Howard HP. Comment on “A Novel Thymoma-Associated Immunodeficiency with Increased Naive T Cells and Reduced CD247 Expression” J Immunol. 2015 Oct 15;195(8):3505
• Fornalski KW, Adams R, Allison W, Corrice LE, Cuttler JM, Davey C, Dobrzyński L, Esposito VJ,Feinendegen LE, Gomez LS, Lewis P, Mahn J, Miller ML, Pennington CW, Sacks B, Sutou S, Welsh JS. The assumption of radon-induced cancer risk. Cancer Causes Control. 2015. Oct; 26(10):1517-8.
• Socol Y, Welsh JS. Regarding the credibility of data showing an alleged association of cancer with radiation from CT scans in childhood. Technol Cancer Res Treat. 2015 Jan 23. pii: 1533034614566923. [Epub ahead of print]
• Seigel J, Welsh JS. Does imaging technology cause cancer? Debunking the LNT myth. Technol Cancer Res Treat. 2016 Apr;15(2):249-56. doi: 10.1177/1533034615578011.
• Siegel JA, Sacks B, Feinendegen LE, Welsh JS, Fornalski KW, Miller M, Mahn J, Gomez L, Stabin MG, Lewis P, Esposito VJ, Strupczewski A, Pennington CW, Cuttler JM, Rangacharyulu C, Davey C, Sutou S. Comment on “Background Ionizing Radiation and the Risk of Childhood Cancer: A Census-Based Nationwide Cohort Study.” Environ Health Perspect. 2015 Aug 1;123(8):A200.
• Welsh J, Bigles C, , Valdebarro A. Future U.S. Supply of Mo-99 Production through Fission Based LEU/LEU Technology. Journal of Radioanalytical & Nuclear Chemistry. 2015;305(1):9-12. Epub 2015 Apr 1.
• Fornalski KW, Cohen M, Cuttler JM, Dobrzyński L, Doss M, Esposito VJ, Feinendegen LE,Fellman A, Miller ML, Orient J, Pennington CW, Rithidech KN, Sacks B, Sanders CL, Scott BR, Siegel JA, Socol Y, Welsh J. French nuclear power plants and childhood leukemia. Dose Response. 2014 Oct 20;12(4):518-21.
• Pollock J and Welsh JS. Clinical Cancer Genetics Part 2: Breast. Am J Clin Oncol. 2014 Feb;37(1):86-9
• R Gupta, Kroc R, Saroja K, Hosmane NS, Welsh JS. Fast Neutron Therapy for Malignant Myxiod Fibrous Histiocytoma Biochemical and Biophysical Journal of Neutron Therapy and Cancer Treatments. VOL2 NO1, PAGES 13-17; 2014
• Chi A, Nguyen NP, Welsh JS, Tse W, Monga M, Oduntan O, Almubarak M, Rogers J, Remick SC, Gius D. Strategies of Dose Escalation in the Treatment of Locally Advanced Non-Small Cell Lung Cancer: Image Guidance and Beyond. Front Oncol. 2014 Jun 20;4:156
• Welsh JS, Gupta R, Young J. Lion(Fish) on the Loose in the Waters off St Vincent. West Indian Med J. 2014 Mar;63(2):179-81.
• Socol Y, Cuttler JM, Dobrzyński L, Doss M, Feinendegen LE, Fornalski KW, Janiak MK, Miller ML, Rithidech KN, Sanders CL, Scott BR, Ulsh B, Vaiserman A and Welsh JS. Comment on “NAIRAS aircraft radiation model development, dose climatology, and initial validation” by Mertens et al.Space Weather, Vol 12, Issue 2, pp 120–121; 2014.
• R Gupta, Reddy Y, Gupta R, Welsh JS, Madani, Hosmane NS. Primary Benign Cystic Retroperitoneal Teratoma in an Asymptomatic Adult. Biochemical and Biophysical Journal of Neutron Therapy and Cancer Treatments. 1(01):5-8; 2013
• Welsh JS. Not all second cancers are secondary. In regard to Mourad et al: “Radiation-induced sarcoma following radiation prophylaxis of heterotopic ossification.” Practical Radiation Oncology. April 2013; 3(2):e35-e36
• Chi A, Wen S, Liao Z, Fowler J, Xu J, Nguyen NP, Welsh JS, Komaki R. What would be the mostappropriate α/β ratio in the setting of stereotactic body radiation therapy for early stage non-small cell lung cancer. Biomed Res Int. 2013;2013
• Sauerwein W, Engenhart-Cabillic R, Forman JD, Guelette J, Hachem S, Jones D, Krüll A, Lukas P, Mandrillon P, Petry W, Rosenberg I, Venimmen F, Welsh JS. Neutron radiotherapy in South Africa: Neutron radiotherapy should continue. S Afr Med J. 2012 Mar 23;102(5):269-70.
• Chi A, Nguyen NP, Xu J, Ji M, Tang J, Jin J, Ong ES, Welsh JS. Correlation of Three Different Approaches of Small Bowel Delineation and Acute Lower Gastrointestinal Toxicity in Adjuvant Pelvic Intensity-Modulated Radiation Therapy for Endometrial Cancer. Technol Cancer Res Treat. 2012 Aug;11(4):353-9. Epub 2012 Mar 28.
• Yadav P, Kozak K, Tolakanahalli R, Ramasubramanian V, Paliwal BR, Welsh JS, Rong Y. Adaptive planning using megavoltage fan-beam CT for radiation therapy with testicular shielding. Med Dosim. Summer 2012; 37,( 2):157-162.
• Chi A, Liao Z, Nguyen NP, Xu J, Welsh JS, Jang SY, Howe C, Komaki R. Dosimetric selection for helical tomotherapy based stereotactic ablative radiotherapy for early-stage non-small cell lung cancer or lung metastases. PLoS One. 2012;7(4):e35809. Epub 2012 Apr 25.
• Rong Y, Yadav P, Welsh JS, Fahner T, Paliwal B. Post-mastectomy Radiotherapy with Integrated Scar Boost using Helical Tomotherapy. Med Dosim. 2012 Feb 23. [Epub ahead of print]
• Alexander Chi, Si Young Jang, James S. Welsh, Nam P. Nguyen, Evan Ong, Lisa Gobar, Ritsuko Komaki. Feasibility of Helical Tomotherapy in Stereotactic Body Radiation Therapy for CentrallyLocated Early Stage Non‒Small-Cell Lung Cancer or Lung Metastases. Int J Radiat Oncol Biol Phys. November 2011; 81(3): 856-862.
• Rong Y, Yadav P, Paliwal B, Shang L, Welsh JS. A planning study for palliative spine treatment using StatRT and megavoltage CT simulation. Journal of Applied Clinical Medical Physics. 2010 Oct 30;12(1):3348
• Y Rong and JS Welsh. Dosimetric and clinical review of helical tomotherapy. Expert Rev Anticancer Ther. 2011 Feb;11(2):309-20.
• Alexander Chi, Siyang Jang, James S. Welsh, Nam P. Nguyen, Ritsuko Komaki. The delivery of steretactic body radiation therapy: a comparsion of Tomotherapy and Volumetric arc therapy. (Submitted to Int J Radiat Oncol Biol Phys)
• Welsh JS. Contagious Cancer. The Oncologist. 2011;16(1):1-4. Epub 2011 Jan 6.
• Chi A, Ma P, Fu G, Hobbs G, Welsh JS, Nguyen NP, Jang SY, Dai J, Jin J, Komaki R. Critical structure sparing in stereotactic ablative radiotherapy for central lung lesions: helical tomotherapy vs. volumetric modulated arc therapy. PLoS One. 2013;8(4):e59729. doi: 10.1371/journal.pone.0059729. Epub 2013 Apr 5.
• Nag S, Demanes DJ, Hagan M, Rivard MJ, Thomadsen BR, Welsh JS, Williamson JF. How to define medical events for brachytherapy – recommendations of the American Society of Radiation Oncology. Practical Radiation Oncology. Volume 1, Issue 4 , Pages 218-223, October 2011.
• Rong Y and Welsh JS. Basics of particle therapy Part II: Biology and dosimetry of hadron therapy. Am J Clin Oncol. 2010 Dec;33(6):646-9
• Chi A, Jang SY, Welsh JS, Nguyen NP, Ong E, Gobar L, Komaki R. Feasibility of Helical Tomotherapy in Stereotactic Body Radiation Therapy for Centrally Located Early Stage Non-small Cell Lung Cancer or Lung Metastases. Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):856-62. Epub 2011 Jan 20.
• Rong Y, Tang G, Welsh JS, Mohiuddin MM, Paliwal B, Yu CX. Helical tomotherapy versus Single- Arc Intensity-Modulated Arc Therapy: A collaborative dosimetric comparison between two institutions. Int J Radiat Oncol Biol Phys. 2011 Jan 13. [Epub ahead of print]
• Rong Y, Welsh JS Surface applicator calibration on the Xoft electronic brachytherapy for non- melanoma skin cancer treatment. Med Phys. 2010 Oct;37(10):5509-17.
• Adkison JB, Tomé W, Seo S, Richards GM, Robins HI, Rassmussen K, Welsh JS, Mahler PA, Howard SP. Reirradiation of Large-Volume Recurrent Glioma with Pulsed Reduced-Dose-Rate Radiotherapy. Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):835-41. Epub 2010 May 14.
• Rong Y, Paliwal B, Howard SP, Welsh JS. Treatment planning for pulsed reduced dose-rate radiotherapy in helical tomotherapy. Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):934-42. Epub 2010 Sep 29.
• Chi A, Tome WA, Fowler J, Komaki R, Nguyen NP, Mehta MP, Welsh JS. Stereotactic Body Radiation Therapy in Non-Small-Cell Lung Cancer: Linking Radiobiological Modeling and Clinical Outcome. American Journal of Clinical Oncology. 2010 Jun 9. [Epub ahead of print]
• Platta CS, Mackay C, Welsh JS. Pituitary Adenoma: A Radiotherapeutic Perspective. Am J Clin Oncol. 2010 Aug;33(4):408-19.
• Pollock J and Welsh JS. Cancer genetics part I: Gastrointestinal. Am J Clin Oncol. 2010 Sep 20. [Epub ahead of print]
• Welsh JS. Helical tomotherapy in the community setting: A personal account. Community Oncology. 2009; 6:463–467.
• Hui SK, Verneris MR, Froelich J, Dusenbery K, Welsh JS. Multimodality Image Guided Total Marrow Irradiation and Verification of the Dose Delivered to the Lung, PTV, and Thoracic Bone in a Patient: A Case Study. Technol Cancer Res Treat. 2009; 8(1):23-28
• Rong Y, Fahner T, Welsh JS. Hypofractionated breast and chest wall irradiation using simultaneous in-field boost IMRT delivered via helical tomotherapy. Technology in Cancer Research and Treatment. 2008; 7(6):415-522.
• Speer T, Welsh JS. The future of radioimmunotherapy for non-Hodgkin lymphoma in the USA. Clin Adv Hematol Oncol. 2008; 6(4):233-37.
• Welsh JS. Basics of particle therapy: Introduction to hadrons. Am J Clin Oncol. 2008;Oct;31(5):493-5.
• Welsh JS. A Potential Means of Investigating the Role of Luteinizing Hormone in the Pathogenesis of Alzheimer Disease. Clinical Medicine and Research. 2008; 6: 1-2.
• Richards GM, Tomé WA, Robins HI, Stewart JA, Welsh JS, Mahler PA, Howard SP. Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region. Breast Cancer Res Treat. 2008 Apr 4.
• Welsh JS, Limmer JP. Image-guided hypofractionated simultaneous in-field boost breast IMRT: In Regard to Freedman et al. Int J Radiation Oncol Biol. Phys. 2007; 69:962.
• Welsh JS, Limmer J. Dosimetric concerns regarding the 4-field box technique. American Journal of Clinical Oncology. 2007 Dec;30(6):666.
• Hong TS, Welsh JS, Ritter MA, M.D., Harari PM, Jaradat H, Mackie TR, Mehta MP. Clinical implementation of megavoltage computer tomography (MVCT): A new tool for image-guided radiotherapy. Am J Clin Oncol. 2007 Dec;30(6):617-23.
• Welsh JS. Applications of beta decay in science and medicine. American Journal of Clinical Oncology. 2007; 30(4):437-439.
• Welsh JS, Limmer J, Mackie TR. High-energy photons in IMRT: Uncertainties and risks for questionable gain. Technology in Cancer Research and Treatment. 2007 6(2):147-50.
• Welsh JS, Howard A, Lucas, D, Hong, HY, Ho T, Reding DJ. Synchronous bilateral breast MALT lymphomas addressed with primary radiation therapy. American Journal of Clinical Oncology. 2006;29(6):634-35.
• Welsh JS, Lock M, Harari PM, Tomé WA, Fowler J, Mackie TR, Ritter M, Kapatoes J, Forrest L,Chappell R, Paliwal B, Mehta MP. Clinical Implementation Of Adaptive Helical Tomotherapy: A Unique Approach To Image-Guided Intensity Modulated Radiotherapy. Technology in Cancer Research and Treatment. 2006; 5(5):465-79.
• Weiss SE, O’Conner L, Welsh JS. Refinement of radiation therapy based on PET data in an adult with Langerhan’s cell histiocytosis of soft tissues. Clin Advances in Hematol Oncol. 2006; 4(4):290- 292.
• Welsh JS, Kennedy AS, Thomadsen B. Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma. Int J Radiat Oncol Biol Phys. 2006; 66(2)S:62-73
• Welsh JS. Beta Radiation. The Oncologist. 2006; 11:181–183
• Welsh JS. Electron capture. American Journal of Clinical Oncology. 2006; 29(6): 540-542.
• Khuntia D, Jaradat H, Orton N, Mehta MP, Tome W, Welsh JS. Helical tomotherapy as a means ofadministering total or partial scalp irradiation. Int J Radiat Oncol Biol Phys. 2006;64(4):1288-9
• Welsh JS. Quarks, Leptons, Fermions and Bosons – The Subatomic World of Radiation Therapy.The Oncologist.11:62–64; 2006.
• Hui SK, Kapatoes J, Fowler J, Henderson D, Olivera G, Manon RR, Gerbi B, Mackie TR, Welsh JS.Feasibility Study of Helical Tomotherapy for Total Body or Total Marrow Irradiation. Med. Phys. 32:3214; 2005.
• Welsh JS, Mehta MP, Mackie TR, Orton N, Jaradat H, Tome W. Helical tomotherapy as a meansof delivering scalp-sparing whole brain radiation therapy. Technology in Cancer Research and Treatment. 4(5):661-2; 2005.
• Welsh JS. Olfactory detection of human bladder cancer by dogs: another cancer detected by “petscan”. BMJ. 2004 Nov 27;329(7477):1286-7
• Welsh JS, Barton D, Ahuja H. A case of breast cancer detected by a pet dog. CommunityOncology. 2005; 2(4): 324-5.
• Welsh JS. Olfactory detection of human bladder cancer by dogs: another cancer detected by “petscan”. BMJ. 2004 Nov 27;329(7477):1286-7
• Orton N, Jaradat H, Welsh JS, Tome W. Whole scalp irradiation using helical tomotherapy. MedicalDosimetry. 2005; 30(3):162-8.
• Duffy BM, Manon R, Patel RR, and Welsh JS. A case of Gorham’s disease with chylothorax treated curatively with radiation therapy. Clin Med Res. 3: 83-86; 2005.
• Chinnaiyan P, Tena LB, Brenner MJ and Welsh JS. Modern External Beam Radiation Therapy forRefractory Dissecting Cellulitis of the Scalp. Brit J Dermatol. 152(4):777-9; 2005
• Welsh JS, Limmer J, Howard SP, Diamond D, Harari PM, Tome W. Precautions in the use of Intensity-ModulatedRadiationTherapy. Technology in Cancer Research and Treatment. Technol Cancer Res Treat. 2005 Apr;4(2):203-10.
• Welsh JS, Berta C, Borzillary S, Sam C, Shickell D, Nobile L, Greenberg M, Weiss S, and DetorieN. Fiducial markers implanted during prostate brachytherapy for guiding conformal external beam radiation therapy. Technology in Cancer Research and Treatment. 3(4):359-64; 2004.
• Potters L, Steinberg M, Rose C, Timmerman R, Ryu S, Hevezi JM, Welsh J, Mehta M, Larson DA, Janjan NA. American Society for Therapeutic Radiology and Oncology and American College of Radiology practice guideline for the performance of stereotactic body radiation therapy. Int JRadiat Oncol Biol Phys. 2004; 60(4):1026-32.
• Hui SK, Das RK, Kapatoes J, Oliviera O, Becker S, Odau H, JD, Patel R, Kuske R, Mehta M,Paliwal B Mackie TR, Fowler JF, Welsh JS. Helical Tomotherapy as a Means of Delivering Accelerated Partial Breast Irradiation. Technology in Cancer Research and Treatment. 3(6):639- 46; 2004.
• Welsh JS. Olfactory detection of human bladder cancer by dogs: another cancer detected by “pet scan”. British Med Journal. 2004 Nov 27;329(7477):1286-7.
• Welsh JS. Dental x-rays and low-birth weight. Antepartum dental radiography and low birth weight. JAMA. 292(9):1019-20; 2004.
• Tome W, Welsh JS, Fowler JF. The effect of fraction time in intensity modulated radiotherapy:theoretical and experimental evaluation of an optimization problem (the real conclusions). Radiotherapy and Oncology. 72(1):113-4; 2004.
• Welsh JS. Fractionated low-dose total body irradiation for Waldenstrom’s macroglobulinemia.Case Reports and Clinical Practice Review. 5:425-431; 2004.
• Welsh JS. Further thoughts on low-level radiation: An evolutionary biologist’s perspective.Radiology. 231:922-3; 2004.
• Fowler JF, Welsh JS, Howard SP. Loss of biological effect in prolonged fraction delivery. Int JRadiat Oncol Biol Phys. 59:242-9; 2004.
• Welsh JS, Bradley K, Manon R, Lock M, Patel R, Ruchala K, Mackie TR, Mehta M. MegavoltageCT imaging for adaptive helical tomotherapy of lung cancer. Clinical Lung Cancer. 5:303-6; 2004.
• Welsh JS. Thymoma and subsequent cancers. Int J Cancer. 108:327; 2004.
• Song DY, Jones R, Welsh J, Haulk TL, Korman LT, Noga S, Goodman S, Herman M, Mann R,Marcellus D, Vogelsang G, Ambinder RF, Abrams RA. Phase I study of escalating doses of low- dose rate, local regional irradiation preceding Cy-TBI for patients with chemotherapy resistant, non-Hodgkin’s or Hodgkin’s lymphoma. Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):166-71.
• Welsh JS, Thurman SA, Howard SP. Thymoma and Multiple Malignancies: A Case of 5 Synchronous Neoplasms and Literature Review. Clinical Medicine & Research. 1:227-32; 2003.
• Welsh JS, Howard SP, Fowler JP. Dose-rate in external beam radiotherapy for prostate cancer –an overlooked confounding variable? Urology. 2003 Aug;62(2):204-6.
• Welsh JS, Thurman SA, Borzillary S, Scwartz C, Howard SP. Samarium-153 EDTMP for recurrentmetastatic osteosarcoma. Clin Adv in Hem Onc. 1(3):63-65; 2003.
• Mackie TR, Kapatoes J, Ruchala K, Lu W, Wu C, Olivera G, Forrest L, Tome W, Welsh J, JerajR, Harari P, Reckwert P, Paliwal B, Ritter MA, Keller H, Fowler J, Mehta M. Image-guidance for precise conformal radiotherapy. Int J Rad Oncol Biol Phys. 2003 May 1;56(1):89-105.
•  Welsh JS, Patel RR, Ritter MA, Harari P, Mackie TR, Mehta MP. Helical Tomotherapy: An Innovative Technology and Approach to Radiation Therapy. Technology in Cancer Research and Treatment. 1:55-63; 2002.
• Song DY, Lawrie WT, Abrams RA, Kafonek DR, Bayless TM, Welsh JS, DeWeese TL. Acute and late radiotherapy toxicity in patients with inflammatory bowel disease. Int J Radiat Oncol Biol Phys. 1;51(2):455-9; 2001.
• Welsh J, Howard S. Acute myelogenous leukemia after exposure to Sr-89 for the treatment of adenocarcinoma of the prostate. (letter) Cancer 89:226-7; 2000.
• Welsh JS, Wilkins KB, Green R, Bulkley G, Askin F, Diener-West M, Howard SP. Association between thymoma and second neoplasms. JAMA. 83(9):1142-3; 2000.
• Welsh J. The Potters article reviewed: Permanent prostate brachytherapy: Lessons learned, lessons to learn. Oncology. July 2000.
• Welsh J, Mayer RR, DeWeese TL. Effects of medical external beam photon irradiation on activity of iodine-125 brachytherapy sources. American Nuclear Society Transactions. 80:82; 1999 106. Welsh J, Yang N, Wharam M, Civelek A, Williams J. Treatment protocol for intracystic P- 32 brachytherapy: Preliminary results. Journal of Brachytherapy International, 15(3-4):211-216; 1999.
• Welsh J, Yanez MH, Chin BB, Howard S. Capromab pendetide (ProstaScint) images before and after salvage radiotherapy. Clinical Nuclear Medicine. 24:983; 1999
• Chin B, Welsh J, Ettinger D, Kleinberg L, White P. Nonsegmental ventilation-perfusion scintigraphy mismatch after radiation therapy. Clinical Nuclear Medicine. 24:54-56;1999.
• Welsh J, Wharam MD, Nauta H, Williams J. Stereotactic radiotherapy for Cushing’s disease and prolactinoma. Journal of Radiosurgery. 2:23-29; 1999
• Welsh J, Torre T, DeWeese T, O’Reilly S. Radiation Myositis. Annals of Oncology 10:1105-8; 1999.
• Wilkins KB, Green R, Patel M, George S, Diener-West M, Welsh J, Howard S, Askin F, Bulkley G. Clinical and pathological predictors of survival in patients with thymoma. Annals of Surgery 230:262-74; 1999
• Welsh J, Wharam MD. Pituitary Adenoma: A review with an emphasis on radiotherapeutic management. Neurosurgery Quarterly 9(3):163-196; 1999.
• Welsh J, Westra W, Eisele D, Hogan H, Lee DJ. Solitary plasmacytoma of the epiglottis – A case report and review of the literature. Journal of Laryngology and Otology 112:174; 1998.
• Mayer R, Welsh J, Mayer-Chen H. Focused neutron beam dose deposition profiles in tissue equivalent materials: A pilot study for BNCT. Proc SPIE 2867:88-91;1997.
• Mayer R, Welsh J, Mayer-Chen H. Neutron beam dose profiles in tissue equivalent materials. American Nuclear Society Transactions. 75:17-18, 1996.

Book chapters

• Rong Y, Welsh JS. “A case study: hypofractionated breast and chest wall irradiation using simultaneous in-field boost IMRT delivered via helical tomotherapy”, Chapter 18, Image guided radiotherapy: A clinical perspective. AJ Mundt and JC Roeske (Editors). B.C. Decker or Toronto, 2011.
• Kennedy A and Welsh J. Radioembolization II: Radioembolization with Yttrium-90 Microspheres for Primary and Metastatic Hepatic Cancer. In Speer T (ed) Targeted Radionuclide Therapy. Pages 305-09. Wolters Kluwer/Lippincott Williams & Wilkins. 2011.
• Welsh JS, Peterson C, Kahl B, Olivera G. Radiotherapy for Hodgkin’s Disease and Non-Hodgkin’s Lymphoma Using Intensity Modulated Radiation Therapy Via Helical Tomotherapy: A New Mantle. In: Intensity Modulated radiation Therapy: A Clinical Perspective. Eds. Mundt AJ and Roeske JC. BC Decker Inc Publishers; 2005.
• Thomadsen B, Welsh J, Hammes R. Microspheres as Microbrachytherapy. In: B Thomadsen, M Rivard, W Butler, Brachytherapy Physics, 2nd edition. Medical Physics Publishing Co., Madison 2005.
• Welsh JS, Olivera G, Mackie TR. Novel clinical applications of IMRT. Medical Physics. 2003. In: Intensity Modulated Radiation Therapy: The state of the art. Mackie TR, Palta JR eds. Medical Physics publishing. 2003.
• Fowler JF, Welsh JS, Tome W. Radiobiology of extracranial stereotactic radiosurgery. Timmerman R and Kavanaugh B (Eds.) Lippincott Williams & Wilkins 2004.
• SP Howard, Robins HI, J Welsh, Tomé WA, Modulation of Dose Rate Effects: Implications for retreatment with ionizing irradiation with minimization of normal neural tissue toxicity while maximizing tumor control probability. Physical, Chemical, and Biological Targeting in Radiation Oncology, Paliwal B, Bentzen SM , Herbert D, Mehta M (eds.), American Association of Physicists in Medicine, College Park, MD, (in press), 2006.
• Mackie TR, Olivera GH, Kapotoes JM, Ruchala KJ, Balog JP, Tome WA, Hui S, Kissick M, Wu C, Jeraj R, Reckwerdt PJ, Harari P Ritter M, Forrest L, Welsh JS, Mehta M. Helical Tomotherapy. In: Intensity Modulated Radiation Therapy: The state of the art. Mackie TR, Palta JR eds. Medical Physics publishing. 2003.
• Frassica D, Thurman S, Welsh J. Management of bone metastases. Orthopedic Clinics of North America. 31:557-66; 2000.

Invited editorials and book reviews

• Welsh JS. Clinical, Technical, and Basic Science Progress in Helical Tomotherapy – The Pace Continues to Accelerate Technol Cancer Res Treat. 2009; 8(1):1-2.
• Welsh JS. Helical Tomotherapy: A Fascinating Technological Concept that has Matured into Clinical Reality. Technology in Cancer Research and Treatment. 2008; 7(6):415-6.
• Welsh JS. ACRO and the American Journal of Clinical Oncology: Year two – the partnership progresses. American Journal of Clinical Oncology. 30(6):569, December 2007
• Welsh JS, Khan M. “Posters Presented at the American College of Radiation Oncology 17th Annual Meeting.” American Journal of Clinical Oncology 30(6); 2007
• Welsh JS. Radiographically identified necrosis after 90Y microsphere brachytherapy: A new standard for oncologic response assessment? American Journal of Roentgenology. 2007; 188:765- 8.
• Welsh JS, Limmer J. Image-guided IMRT (book review) Int J Radiat Oncol Biol Phys. 2006; 65(4):1270-1271
• Welsh JS, Khan M. The American Journal of Clinical Oncology and the American College of Radiation Oncology – A perfect couple. American Journal of Clinical Oncology. 2006; 29(6): 536.
• Welsh JS. IMRT 2006: Technology, Research & Cancer Treatment. Technology in Cancer Research and Treatment. 2006. 2006; 5(5):445-6.

Practice guidelines

• Potters L Kavanagh B, Galvin JM, Hevezi JM, Janjan NA, Larson DA, Mehta MP, Ryu S, Steinberg M, Timmerman R, Welsh JS, Rosenthal SA. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):326-32
• Microbrachytherapy: Radioimmunotherapy and microsphere therapy. ASTRO practice guide.
• American College of Radiology (ACR) Radiation Oncology Carrier Advisory Committee (CAC) Network Model Policy on Microspheres Hepatic Brachytherapy.
• American College of Radiology: Practice Guideline for the Radioembolization with microsphere brachytherapy device (RMBD) for treatment of liver malignancies. 2008
• Potters L, Steinberg M, Rose C, Timmerman R, Ryu S, Hevezi JM, Welsh J, Mehta M, Larson DA, Janjan NA. American College of Radiology: Practice Guideline for the Performance of Stereotactic Body Radiation Therapy. ACR Practice Guidelines and Technical Standard. pp. 629-636, 2004.

Articles in Popular Journals

• James Welsh. “Disappearing Act.” Vital Signs section of Discover Magazine. March 2014. pages 24- 6.5
• Welsh JS. Quarks, leptons, bosons, and fermions: the pharmacology of radiation therapy. Science & Medicine. 10(2):124-36; 2005.
• Welsh J, Berta C. Radioimmunotherapy for Non-Hodgkin’s Lymphoma. Science & Medicine. 8(5),46-57; 2002.
• Welsh J. Radiation and Cancer. 21st Century Science and Technology. 15(1):3-4; 2002.
• James S. Welsh, M.D. and Jeffry A. Siegel. “Why What You Think About Radiation Might Just Be Wrong. New evidence suggests those warnings about low-dose exposure in any setting were ill-founded.” US News and World Report. April 21, 2016, Accessed last on 28- 06 -2016.

Online articles

• James S. Welsh and Codi William Halbur. Cancer is not always a non-communicabledisease. CA: A cancer journal for clinicians. (e-letter available at: http://caonline.amcancersoc.org/cgi/eletters/59/5/282)
• Cuttler J, Pollycove M, Welsh J. Application of Low Doses of Radiation for Curing Cancer.Radiation Science and Health Newsletter. Available at http://cnts.wpi.edu/rsh/Docs/Cuttler_et_al.htm
• Welsh JS. Another cancer detected by “pet scan.” British Medical Journal. On-line. Oct 15, 2004. Available at: http://bmj.bmjjournals.com/cgi/eletters/329/7468/712#78342

Non-peer reviewed manuscripts and acknowledgements

• 1. Siegel JA, Marcus CS, Welsh JS, Pennington CW, Stabin MG (2016) Regulatory application of the LNT hypothesis and ALARA to protect radiosensitive people is misguided. Health Physics News XLIV: 23-24.
• Co-Editor: American College of Radiation Oncology Practice Management Guide. 2005.
• Pollycove M, Welsh J. Application of Low Doses of Radiation for Curing Cancer. American Nuclear Society Bulletin, April 2000.
• Welsh J, Thurman SA.. Samarium-153 lexidronam combined withexternal beam radiation for the treatment of bone metastases. Case Studies in Oncology. 2(5):1-7; June, 2000.
• Cuttler J, Pollycove M, Welsh J. Application of Low Doses ofRadiation for Curing Cancer. Canadian Nuclear Society Bulletin, Vol. 21, pp. 45, Aug 2000.
• Jeffrey J. Popma, MD; Mohan Suntharalingam, MD; Alexandra J.Lansky, MD; et al. for the Stents And Radiation Therapy (START) Investigators* (one of the contributing investigators in this study) Randomized trial of 90Sr/90Y-radiation versus placebo control for treatment of in-stent restenosis. Circulation 2002;106;1090-1096.

Books

James S. Welsh, MD: “Sharks Get Cancer, Mole Rats Don’t: How Animals Could Hold the Key to Unlocking Cancer Immunity in Humans” Published by Prometheus Books.
Distributed by Penguin Random House
Released March 29, 2016 ISBN: 9781633881549
Published: 15/04/2016
Imprint: Prometheus Books

Hospital Clinical Program Development & Leadership

• Initiator of the GRID and Pulsed Low Dose Rate clinical programs for the Hines VA Radiation Oncology Dept (2016)
• Initiator and clinical leader of the Proton Beam Therapy clinical program for Loyola University Radiation Oncology (At the ProCure/CDH(2015)
• Creation of Cancer Genetics Testing and Counseling Program (2006) UW Cancer Center/Riverview Hospital
• Clinical Leader (Radiation Oncology) of Microsphere Brachytherapy Program (2003) University of Wisconsin Hospital and Clinics
• Initiator of Thyroid Cancer and Hyperthyroidism Radioiodine Therapy Program (2006) UW Cancer Center/Riverview Hospital
• Initiation of Electronic Brachytherapy Program (2009) UW Cancer Center/Riverview Hospital
• Founder of the Radiological Disaster Subcommittee, Riverview Hospital 2007
• Creation of Image-guided Intensity Modulated Radiation Therapy Program (2004) UW Cancer Center/Riverview Hospital
• Creation of TomoTherapy IG-IMRT Program (2006) UW Cancer Center/Riverview Hospital
• Clinical Leader, Nucleotron SPOT-PRO Robotic Prostate Brachytherapy Program (2002) University of Wisconsin Hospital and Clinics
• Clinical Leader (Radiation Oncology), BetaCath Intravascular Brachytherapy Program The John Hopkins Hospital 2000-2001
• Clinical Director of Prostate Brachytherapy Program The John Hopkins Hospital 1999-2001
• Clinical Leader (Radiation Oncology) Lymphoma Radioimmunotherapy Program The John Hopkins Hospital 1998-2001